WO2023093733A1 - Ablation system - Google Patents

Ablation system Download PDF

Info

Publication number
WO2023093733A1
WO2023093733A1 PCT/CN2022/133571 CN2022133571W WO2023093733A1 WO 2023093733 A1 WO2023093733 A1 WO 2023093733A1 CN 2022133571 W CN2022133571 W CN 2022133571W WO 2023093733 A1 WO2023093733 A1 WO 2023093733A1
Authority
WO
WIPO (PCT)
Prior art keywords
tube
fluid
ablation system
distal end
expandable
Prior art date
Application number
PCT/CN2022/133571
Other languages
French (fr)
Chinese (zh)
Inventor
段超
刘成
Original Assignee
杭州德诺电生理医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 杭州德诺电生理医疗科技有限公司 filed Critical 杭州德诺电生理医疗科技有限公司
Publication of WO2023093733A1 publication Critical patent/WO2023093733A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/28Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
    • A61B5/283Invasive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/367Electrophysiological study [EPS], e.g. electrical activation mapping or electro-anatomical mapping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00613Irreversible electroporation

Definitions

  • the present application relates to the technical field of medical devices, in particular to an ablation system.
  • the present application provides an ablation system, including a first catheter and a second catheter.
  • the first conduit includes a flow channel and an expandable member, the flow channel includes a first fluid channel and a second fluid channel isolated from each other; the expandable member is sleeved on the flow channel, the first fluid The channel is used to provide a first fluid to the expandable member to expand the expandable member; the second fluid channel is used to provide a second fluid for ablation to the target tissue area; the second catheter is passed through In the flow conduit, the second conduit is exposed from the distal end of the flow conduit for potential mapping.
  • the distal end of the second catheter when the second fluid is provided through the second fluid channel of the first catheter to ablate the target tissue area, the distal end of the second catheter can perform potential mapping at the same time, which realizes centering during the ablation process.
  • Real-time monitoring of the internal potential and can judge the ablation effect according to the real-time monitoring of the intracardiac potential, so as to achieve a good therapeutic purpose.
  • re-ablation can be performed directly through the first catheter, and potential mapping can be performed synchronously through the distal end of the second catheter.
  • the ablation system Compared with related schemes where ablation and mapping can only be performed separately (correspondingly, catheters for ablation or mapping need to be fed into and withdrawn from the body separately), the ablation system provided by this application can perform intracardiac potential while ablation
  • the measurement greatly simplifies the operation steps, shortens the operation time, can perform ablation treatment quickly, and can judge the ablation effect according to the monitored intracardiac potential, guarantees the ablation effect, and can achieve a good therapeutic purpose.
  • Fig. 1 is a schematic diagram of an ablation system provided in the first embodiment of the present application.
  • FIG. 2 is a schematic diagram of removing a second catheter by the ablation system shown in FIG. 1 .
  • Fig. 3 is a schematic cross-sectional view of the inner tube and the outer tube of the flow channel.
  • Figure 4 is a schematic view of the distal end of the first catheter.
  • FIG. 5 is an enlarged schematic diagram of a local area of FIG. 4 .
  • FIG. 6 is a schematic cross-sectional view of the structure shown in FIG. 5 along the line A-A.
  • FIG. 7 is an enlarged schematic view of the region of the distal portion of the first catheter shown in FIG. 4 .
  • Fig. 8 is a schematic diagram of the assembly of the second pipe body, the sealing gasket, the tail cap and the second conduit.
  • Figure 9 is a schematic diagram of a second catheter.
  • Fig. 10, Fig. 11 and Fig. 12 are schematic diagrams of possible structures of the bearing part in some other embodiments.
  • Fig. 13 is a schematic diagram of an ablation system provided in the second embodiment of the present application.
  • FIG. 14 is a schematic diagram of removing the second catheter by the ablation system shown in FIG. 13 .
  • FIG. 15 is an enlarged schematic diagram of a partial area of the ablation system shown in FIG. 14 .
  • FIG. 16 is a schematic cross-sectional view of the structure shown in FIG. 15 along line B-B.
  • Fig. 17 is a schematic diagram of the assembly of the connecting pipe and the inner pipe in one embodiment of the present application.
  • Fig. 18 is a schematic diagram of an ablation system provided in the third embodiment of the present application.
  • Fig. 19 is a schematic diagram of removing the second catheter by the ablation system shown in Fig. 18 .
  • FIG. 20 is an enlarged schematic diagram of a partial area of the ablation system shown in FIG. 19 .
  • FIG. 21 is a schematic cross-sectional view of the structure shown in FIG. 20 along line C-C.
  • Fig. 22 is a schematic diagram of an ablation system provided in a fourth embodiment of the present application.
  • FIG. 23 is a schematic cross-sectional view of the structure shown in FIG. 22 along line D-D.
  • Fig. 24 is a schematic diagram of an ablation system provided in a fifth embodiment of the present application.
  • FIG. 25 is an enlarged schematic diagram of a partial area of the ablation system shown in FIG. 24 .
  • Fig. 26 is a schematic diagram of an ablation system provided in the sixth embodiment of the present application.
  • FIG. 27 is a schematic cross-sectional view of the flow channel of the ablation system shown in FIG. 26 .
  • FIG. 28 is an enlarged schematic diagram of a partial area of the ablation system shown in FIG. 26 .
  • FIG. 29 is a schematic diagram of the first catheter of the ablation system shown in FIG. 26 .
  • connection and “connection” mentioned in this application all include direct and indirect connection (connection) unless otherwise specified.
  • the orientation close to the operator is generally defined as the proximal end, and the orientation away from the operator is defined as the distal end;
  • the direction of the rotation center axis of objects such as cylinders and tubes is defined as the axial direction,
  • a direction perpendicular to the axial direction is defined as a radial direction.
  • the first embodiment of the present application provides an ablation system 100A, which is used to ablate the target tissue area by means of chemical ablation therapy to achieve the effect of electrical isolation, and can perform cardiac ablation at the same time. Internal potential measurement.
  • the target tissue area can be located in the heart, including but not limited to the vein of Marshall. It can be understood that the target tissue area is not limited to be located on the heart, but may also be located on other body tissues, which is not limited here.
  • the ablation system 100A includes a first catheter 10 and a second catheter 30 .
  • the first catheter 10 is used to ablate a target tissue region.
  • the first catheter 10 includes a flow conduit 11 and an expandable member 13 .
  • the flow channel 11 includes a first fluid channel 111 and a second fluid channel 113 which are isolated from each other.
  • the expandable member 13 is sheathed on the flow channel 11 .
  • the first fluid channel 111 is used to provide the first fluid to the expandable member 13 to expand the expandable member 13 to achieve occlusion of blood vessels.
  • the second fluid channel 113 is used to provide a second fluid for ablation to the target tissue area.
  • the second conduit 30 is passed through the flow conduit 11 , and the second conduit 30 is exposed from the distal end of the flow conduit 11 for potential mapping.
  • the distal end of the second catheter 30 can simultaneously perform potential mapping.
  • Real-time monitoring of intracardiac potential and can judge the ablation effect according to the real-time monitoring of intracardiac potential, so as to achieve the purpose of good treatment.
  • the ablation system 100A in this embodiment can perform intracardiac potential Measurement does not require separate operations for ablation and mapping, which greatly simplifies the operation steps and shortens the operation time.
  • the flow channel 11 includes an inner tube 114 and an outer tube 115 .
  • the inner tube 114 passes through the outer tube 115 .
  • the outer wall of the inner tube 114 and the inner wall of the outer tube 113 jointly enclose the first fluid channel 111 .
  • the distal end of the first fluid channel 111 is closed.
  • the inner tube 114 is provided with a second fluid passage 113 .
  • the second conduit 30 passes through the second fluid channel 113 .
  • the proximal end of the second conduit 30 exposes the proximal end of the inner tube 114
  • the distal end of the second conduit 30 exposes the distal end of the inner tube 114 .
  • the expandable member 13 is sheathed on the inner tube 114 , and the proximal end of the expandable member 13 is fixedly connected with the distal end of the outer tube 115 and communicated with the first fluid channel 111 .
  • the inner tube 114 and the outer tube 115 are arranged coaxially, and the distal end of the inner tube 114 exposes the distal end of the outer tube 115 .
  • the inner tube 114 and the outer tube 115 are made of nylon (polyamide, PA). It can be understood that, in other embodiments, the inner tube 114 and the outer tube 115 may not be arranged coaxially, and the application does not limit the materials of the inner tube 114 and the outer tube 115 .
  • the inner diameter of the inner tube 114 ranges from 0.55 mm to 1.40 mm
  • the inner diameter of the outer tube 115 ranges from 0.85 mm to 1.70 mm.
  • the inner diameter of the inner tube 114 is 0.70 mm
  • the inner diameter of the outer tube 115 is 1.20 mm.
  • the application does not limit the inner diameter range of the inner tube 114
  • the application does not limit the inner diameter range of the outer tube 115 .
  • the expandable member 13 includes a first expandable part 131 and a second expandable part 133 arranged along the axial direction of the flow channel 11 .
  • the first expandable part 131 is fixedly connected with the second expandable part 133 .
  • the first expandable member 131 and the second expandable member 133 are arranged in series along the axial direction of the flow channel 11 to improve the effect of the expandable member 13 on blood vessel occlusion.
  • the first expandable element 131 has a first cavity 1310 (as shown in FIG. 4 ), and the second expandable element 133 has a second cavity 1330 (as shown in FIG. 4 ).
  • the first cavity 1310 communicates with the second cavity 1330
  • the second cavity 1330 communicates with the first fluid channel 111 .
  • the first fluid channel 111 is used to input the first fluid into the first cavity 1310 and the second cavity 1330 .
  • the distal end of the inner tube 114 passes through the second cavity 1330 of the second expandable element 133 and the first cavity 1310 of the first expandable element 131 in turn.
  • the distal end of the outer tube 115 is fixedly connected to the proximal end of the second expandable member 133 .
  • the first expandable member 131 is roughly in the shape of a balloon
  • the second expandable member 133 is roughly in the shape of a balloon.
  • the distance between the center of the first expandable part 131 and the center of the second expandable part 133 ranges from 4 mm to 12 mm, for example, the distance between the center of the first expandable part 131 and the center of the second expandable part 133 is 6mm.
  • both the first inflatable member 131 and the second inflatable member 133 are semi-compliant balloons, so as to improve the sealing effect of the balloons.
  • Semi-compliant balloons have a wide working range, can flexibly manipulate the size of the balloon, and are mostly used for pre-dilation.
  • the material of the first expandable member 131 and the second expandable member 133 includes one of polyether block amide (polyether block amide, PEBAX), PA, thermoplastic polyurethane elastomer rubber (thermoplastic polyurethanes, TPU). It can be understood that the present application does not limit the materials of the first expandable element 131 and the second expandable element 133 .
  • the expandable member 13 includes an expanded state and a non-expanded state.
  • the expandable member 13 is expanded by the first fluid provided by the first fluid channel 111 to be able to occlude the blood vessel.
  • the volume of the expandable member 13 in the expanded state is larger than the volume of the expandable member 13 in the non-expanded state.
  • the shape of the first expandable part 131 and the shape of the second expandable part 133 may be a hollow cylindrical shape as shown in FIG. 4 .
  • the axial length of the first expandable element 131 is greater than the maximum outer diameter of the first expandable element 131
  • the axial length of the second expandable element 133 is greater than the maximum outer diameter of the second expandable element 133 .
  • the present application does not limit the shape of the first expandable member 131 , for example, it may be heart-shaped, square, spherical and so on.
  • the present application does not limit the shape of the second expandable member 133 , for example, it may be heart-shaped, square, spherical and so on.
  • the expandable member 13 further includes a connecting pipe 135 outside the flow channel 11 for connecting the first expandable part 131 and the second expandable part 133 .
  • the distal end of the connecting tube 135 is fixedly connected to the proximal end of the first expandable element 131
  • the proximal end of the connecting tube 135 is fixedly connected to the distal end of the second expandable element 133 .
  • the connecting tube 135 has a lumen 1350 , and the lumen 1350 communicates with the first cavity 1310 and the second cavity 1330 , so that the first fluid input into the second cavity 1330 enters the first cavity 1310 through the lumen 1350 .
  • the distal end of the inner tube 114 also passes through the lumen 1350 .
  • the connecting tube 135 is fixedly connected to the proximal end of the first expandable member 131 by laser welding, and the connecting tube 135 is fixedly connected to the distal end of the second expandable member 133 by laser welding. It can be understood that the present application does not limit the fixed connection method between the connecting pipe 135 and the first expandable member 131 , and the present application does not limit the fixed connection method between the connecting pipe 135 and the second expandable member 133 .
  • the axial length of the connecting pipe 135 is not less than 6 mm
  • the inner diameter of the connecting pipe 135 is approximately the same as the outer diameter of the distal end of the outer pipe 115
  • the material of the connecting pipe 135 is the same as that of the outer pipe 115 . It can be understood that the present application does not limit the length of the connecting pipe 135 , and the present application does not limit the outer diameter and material of the connecting pipe 135 .
  • a breach 1351 is provided on the tube wall of the connecting tube 135 to expose part of the inner tube 114 .
  • the breach 1351 is roughly rectangular. It can be understood that the present application does not specifically limit the shape of the opening 1351 , for example, it may be circular, oval, rectangular, or irregular.
  • the flow pipe 11 passes through the side wall of the inner tube 114 to define an injection through hole 119 for injecting the second fluid, and the position of the injection through hole 119 corresponds to the position of the breach 1351 .
  • the injection through hole 119 is substantially circular.
  • the inner wall of the lumen 1350 includes a first sealing area 1353 disposed around the periphery of the breach 1351 .
  • the flow pipe 11 is provided with a second sealing area 1133 around the injection hole 119 .
  • the first sealing area 1353 is in sealing connection with the second sealing area 1133 to ensure the sealing connection between the edge of the opening 1351 and the inner tube 114 .
  • the first sealing area 1353 and the second sealing area 1133 can be hermetically connected by heat fusion or the like.
  • the expandable member 13 adopts a series-type double-balloon structure.
  • the injection through hole 119 can ablate the target tissue area.
  • the middle section and the proximal section of the tissue area spray the second fluid, therefore, it is not necessary to perform operations such as expansion, contraction, and retraction on the expandable member 13 multiple times to complete the treatment of the distal section, the middle section, and the proximal section of the target tissue area. Injection of the fluid, only one expansion and contraction of the expandable member 13 is required to complete the injection and ablation of the second fluid to the entire target tissue area.
  • the inflatable member 13 after the inflatable member 13 adopts a series-type double-balloon structure, it can not only achieve simultaneous ablation and mapping, but also complete the ablation of the entire target tissue area with only one operation, which further simplifies the operation to a greater extent. The steps shorten the operation time and can realize rapid ablation treatment.
  • the first conduit 10 further includes a first developing object 141 and a second developing object 143 .
  • the first developing object 141 is located at the position of the inner tube 114 corresponding to the first expandable member 131 , so as to mark the position of the first expandable member 131 when the ablation system 100A performs an operation.
  • the second developing object 143 is located at the position of the inner tube 114 corresponding to the second expandable member 133, so as to mark the position of the second expandable member 133 when the ablation system 100A performs an operation.
  • Both the first developing object 141 and the second developing object 143 are made of X-ray opaque material.
  • each of the first developing object 141 and the second developing object 143 is arranged on the outer wall of the inner tube 114 and arranged around the circumference of the inner tube 114 to form a ring-shaped developing structure.
  • the first developing object 141 is roughly Set in the middle of the first expandable part 131
  • the second developing object 143 is roughly arranged in the middle of the second expandable part 133, so that the operation process can be determined through the development of the first developing object 141 and the second developing object 143
  • the position of the inflatable member, and the two developers are arranged in a ring around the inner tube 114 to improve the developing effect.
  • the first developer 141 may be located on the first expandable member 131
  • the second developer 143 may be located on the second expandable member 133 .
  • the first catheter 10 further includes a head end 15 disposed at a distal end of the inner tube 114 .
  • the outer diameter of the head end 15 decreases from the proximal end of the head end 15 to the distal end of the head end 15.
  • the head end 15 is generally in the shape of a truncated cone to improve the tracking of the first catheter 10, and the first catheter 10 enters the blood vessel smoothness.
  • the head end 15 includes a hollow cavity 150 in communication with the second fluid passage 113 .
  • the second catheter 30 passes through the head end 15 and emerges from the distal end of the head end 15 .
  • the hardness of the head end 15 is greater than the hardness of the inner tube 114, so as to improve the smoothness of the first catheter 10 entering narrow blood vessels.
  • the axial length of the head end 15 ranges from 1 mm to 3 mm, for example, the axial length of the head end 15 is 2 mm. It can be understood that the present application does not limit the hardness and axial length of the head end 15 .
  • the first catheter 10 can It includes a protective layer (not shown) coated on the outer wall of the head end 15 .
  • the material of the protective layer is relatively soft, so as to reduce the damage to the blood vessel when the head end 15 enters the blood vessel.
  • the material of the protective layer includes but is not limited to polytetrafluoroethylene (polytetrafluoroethylene, PTFE).
  • the distal peripheral wall of the head end 15 is provided with an injection port 151 communicating with the hollow cavity 150 of the head end 15 .
  • the injection port 151 is used to inject the second fluid.
  • the hollow cavity 150 and the injection port 151 can inject the second fluid at the same time, so as to increase the injection area of the second fluid, thereby improving the ablation efficiency.
  • the number of injection ports 151 may be one or more. When the number of injection ports 151 is more than one, the one or more injection ports 151 are provided along the circumferential direction of the head end 15 .
  • a step 153 is formed on the inner wall of the hollow cavity 150 . The distal end of the inner tube 114 is received in the hollow cavity 150 and abuts against the step 153 .
  • the step 153 is used to limit the head end 15 when mating with the inner tube 114 , so as to increase the connection stability between the head end 15 and the inner tube 114 .
  • the first conduit 10 further includes a first connector 16 and a second connector 17 .
  • the first connector 16 is fixedly sleeved on the proximal end of the outer tube 115 of the flow channel 11 , and the first connector 16 is used for providing the first fluid to the first fluid channel 111 .
  • the proximal end of the inner tube 114 of the flow channel 11 is fixedly connected to the distal end of the second connector 17 , and the second connector 17 is used to provide the second fluid to the second fluid channel 113 .
  • the first connector 16 includes a first tube body 161 and a first injection tube 163 that are fixedly connected.
  • the first pipe body 161 is connected with the first injection pipe 163 to form a Y-shaped structure.
  • the first injection pipe 163 has a first fluid injection port 1631 .
  • Both the outer tube 115 and the inner tube 114 of the circulation channel 11 pass through the first tube body 161 .
  • the inner tube 114 exposes the proximal end of the first tube body 161 .
  • the first injection pipe 163 communicates with the first fluid passage 111 .
  • the first fluid injection port 1631 is used for injecting the first fluid into the first tube body 161 and flowing into the first fluid channel 111 through the first injection tube 163 to inflate the expandable member 13 .
  • the proximal end of the first tube body 161 can be fixedly connected with the inner tube 114 passing through the first tube body 161 through glue or injection molding to reduce the possibility of relative movement between the first tube body 161 and the inner tube 114
  • the axial distance between the distal end of the second connector 17 and the proximal end of the first connector 16 includes but is not limited to 100mm-200mm.
  • the second connector 17 includes a second tube body 171 and a second injection tube 173 that are fixedly connected.
  • the second pipe body 171 is connected with the second injection pipe 173 to form a Y-shaped structure.
  • the second injection pipe 173 has a second fluid injection port 1731 .
  • the distal end of the second tube body 171 is fixedly connected with the proximal end of the inner tube 114 of the flow channel 11 .
  • the second tube body 171 communicates with the second fluid channel 113 .
  • the second fluid injection port 1731 is used for injecting the first fluid into the second tube body 171 and flowing into the second fluid channel 113 through the second injection tube 173 .
  • the proximal end of the second tube body 171 can be fixedly connected with the inner tube 114 passing through the second tube body 171 through glue or injection molding to reduce the possibility of relative movement between the second tube body 171 and the inner tube 114 .
  • the second tube body 171 includes a first insertion hole 1711 arranged along the axial direction of the second tube body 171 , and the proximal end surface of the second tube body 171 is provided to communicate with the first insertion hole 1711 Flaring 1713.
  • the first conduit 10 also includes a gasket 18 .
  • the gasket 18 is accommodated in the flaring opening 1713 and sealed with the second tube body 171 to prevent blood and the second fluid from overflowing.
  • the outer diameter of the gasket 18 may be slightly larger than the diameter of the flaring 1713 .
  • the material of the gasket 18 includes but is not limited to silica gel.
  • the gasket 18 is provided with a second insertion hole 181 .
  • the second conduit 30 passes through the first insertion hole 1711 and the second insertion hole 181 .
  • the first catheter 10 further includes a tail cap 19 fixedly connected to the proximal end of the second tube body 171 .
  • the outer wall of the second pipe body 171 is provided with an external thread 1715
  • the tail cap 19 is provided with an internal thread (not shown) adapted to the external thread 1715
  • the second pipe body 171 is screwed to the tail cap 19.
  • the gasket 18 is fixedly accommodated in the tail cap 19 .
  • the proximal end of the tail cap 19 is provided with a conduit hole 191 .
  • the second conduit 30 passes through the conduit hole 191 .
  • the second catheter 30 includes a metal shaft tube 31 , a flexible tube 32 , an electrode 33 , a support wire 34 and an electrical connector 35 .
  • the distal end of the metal shaft tube 31 is fixedly connected with the proximal end of the flexible tube 32 .
  • the proximal end of the metal shaft tube 31 is fixedly connected with the electrical connector 35 .
  • the material of the flexible tube 32 includes but is not limited to a resin material, for example, the resin material includes thermoplastic polyurethane elastomer rubber (thermoplastic polyurethanes, TPU) or pebax.
  • the proximal end of the flexible tube 32 is provided with a flaring structure (not shown in the figure) to facilitate the insertion of the metal shaft tube 31 , thereby facilitating the assembly between the proximal end of the flexible tube 32 and the metal shaft tube 31 .
  • the distal end of the metal shaft tube 31 is inserted into the proximal flaring structure of the flexible tube 32 and bonded with glue, and the proximal end of the metal shaft tube 31 is connected to the electrical connector 35 through glue bonding.
  • the material of the metal shaft tube 31 is not specifically limited, and may be metal materials such as stainless steel and nickel-titanium alloy.
  • the inner diameter of the flexible tube 32 may range from 0.25 mm to 1.2 mm, for example, the inner diameter of the flexible tube 32 may be 0.35 mm. It can be understood that the connection method between the metal shaft tube 31 and the flexible tube 32 is not limited to bonding, for example, it may also be snap-fitting or the like.
  • the flexible tube 32 includes a bearing portion 321 and a connecting portion 323 .
  • the distal end of the connecting portion 323 is fixedly connected to the proximal end of the carrying portion 321 .
  • the flaring structure is disposed at a proximal end of the connecting portion 323 .
  • the inner diameter of the flaring structure is slightly larger than the outer diameter of the distal end of the metal shaft tube 31 .
  • the connecting portion 323 is passed through the inner tube 114 of the flow channel 11 .
  • the carrying portion 321 is located outside the flow channel 11 , and the electrodes 33 are disposed on the carrying portion 321 .
  • the electrode 33 is disposed at the distal end of the flexible tube 32 and is electrically connected to the electrical connector 35 for potential mapping.
  • the electrodes 33 include ring electrodes 331 and head electrodes 333 . Both the ring electrode 331 and the head electrode 333 are used for potential mapping.
  • the ring electrode 331 is sheathed on the bearing portion 321 of the flexible tube 32 and is electrically connected to the electrical connector 35 through the wire 37 .
  • there are multiple ring electrodes 331 and the multiple ring electrodes 331 are arranged along the axial direction of the flexible tube 32 .
  • Each ring electrode 331 is connected to the electrical connector 35 through a wire 37 so as to be able to control the voltage applied to the ring electrodes 331 respectively.
  • the wire 37 includes, but is not limited to, an enameled copper wire.
  • the head electrode 333 is fixed on the farthest end of the flexible tube 32 , and the head electrode 333 is electrically connected to the electrical connector 35 through a wire 37 .
  • the wire 37 is connected to the ring electrode 331 and the head electrode 333 by welding or other connection methods.
  • the electrode 33 may omit the head electrode 333 and perform potential mapping through the ring electrode 331 .
  • the electrode 33 may also be configured to generate a pulse electric field for pulse ablation of the target tissue region.
  • Pulse ablation uses a high-intensity pulsed electric field to cause irreversible electrical breakdown of the cell membrane, which is called irreversible electroporation (IRE) in the medical field, to cause cell apoptosis to achieve non-thermal ablation of cells, so it is not affected by the heat sink effect.
  • IRE irreversible electroporation
  • the high-voltage pulse sequence produces less heat and does not need saline irrigation for cooling, which can effectively reduce the occurrence of gas explosion, eschar and thrombus.
  • the pulse ablation treatment time is short, the treatment time of applying a set of pulse sequences is less than 1 minute, and the whole ablation time is generally no more than 5 minutes. And because different tissues have different response thresholds to pulsed electric fields, it is possible to ablate the myocardium without disturbing other adjacent tissues, thereby avoiding accidental injury to adjacent tissues. In addition, compared with other energies, pulse ablation does not require heat conduction to ablate deep tissues, and all cardiomyocytes distributed above a certain electric field strength will undergo electroporation, which reduces the pressure requirements for catheter abutment during ablation. Therefore, even if the ablation device does not completely adhere to the inner wall of the tissue, the ablation effect of IRE will not be affected.
  • high voltage pulses may be selected as the form of energy delivered through electrodes 33, other forms of energy may additionally or alternatively be delivered, such as radio frequency energy or any other suitable form of energy. That is, the electrodes 33 may also be configured to transmit radiofrequency energy or other suitable forms of energy (eg, microwaves) to perform ablation treatment on the target tissue region.
  • radiofrequency energy e.g, microwaves
  • the supporting wire 34 passes through the flexible tube 32 for supporting the flexible tube 32 .
  • the support wire 34 includes a small diameter portion (not shown) located at the distal end of the support wire 34 and a large diameter portion (not shown) located at the proximal end of the support wire 34 .
  • the outer diameter of the large-diameter portion is greater than that of the small-diameter portion, and the small-diameter portion passes through the bearing portion 321 and the connecting portion 323 of the flexible tube 32 .
  • the support wire 34 includes but is not limited to nickel-titanium alloy.
  • the support wire 34 has superelasticity and memory properties, and plays a supporting role to ensure the rigidity of the distal end of the second catheter 30 .
  • the diameter of the support wire 34 ranges from 0.10 mm to 0.40 mm, for example, the diameter of the support wire 34 is 0.18 mm.
  • the electrical connector 35 is used to connect the wire 37 with the monitoring equipment.
  • one end of the electrical connector 35 is provided with pins for connecting the welding wire 37 , and the other end is provided with an interface structure for quick connection with monitoring equipment.
  • the bearing part 321 includes a helical structure 3213, the helical structure 3213 extends helically along the axial direction of the connecting part 323, the ring electrode 331 is arranged on the helical structure 3213, and the head electrode 333 is arranged on the At the farthest end of the bearing part 321, the radial dimension of the helical structure is equivalent to the diameter of the blood vessel. In this way, the ring electrode 331 on the bearing part 321 can be better attached to the blood vessel wall, which is beneficial to improve the heart rate. The accuracy of the internal potential measurement.
  • the radial dimension of the helical structure refers to the dimension in the direction perpendicular to the axial direction of the helical structure.
  • the carrying portion 321 includes a curved structure 3215 , and the curved structure 3215 is disposed at the farthest end of the carrying portion 321 and is bent relative to the axial direction of the connecting portion 323 .
  • the bending angle range of the curved structure 3215 relative to the axial direction of the connecting portion 323 or the axial direction of the first conduit is not less than 90° and not greater than 150°, that is, the bending angle range of the curved structure 3215 relative to the axis of the connecting portion 323 is [90°,150°].
  • the angle between the vein of Marshall and the coronary sinus is approximately 90° to 150°. Since the bending angle of the curved structure 3215 relative to the axis of the connecting portion 323 is approximately the same as the angle between the vein of Marshall and the coronary sinus, in this way, the second catheter 30 can enter the blood vessel well without greatly Increase manufacturing cost.
  • the bearing part 321 includes a helical structure 3213 and a curved structure 3215, the helical structure 3213 extends helically along the axial direction of the connecting part 323, and the ring electrode 331 is disposed on the helical structure 3213.
  • the head electrode 333 is disposed at the farthest end of the bearing portion 321
  • the curved structure 3215 is disposed at the farthest end of the bearing portion 321 and bent relative to the axial direction of the connecting portion 323 .
  • the bearing part 321 combines the helical structure 3213 and the curved structure 3215, wherein the helical structure 3213 can make the ring electrode 331 on the bearing part 321 and the blood vessel wall can be better attached to, thereby helping to improve the accuracy of intracardiac potential measurement .
  • the bending angle range of the curved structure 3215 relative to the axial direction of the connecting portion 323 or the axial direction of the first conduit is not less than 90° and not greater than 150°, that is, the bending angle range of the curved structure 3215 relative to the axis of the connecting portion 323 is [90°,150°].
  • the angle between the vein of Marshall and the coronary sinus is approximately 90° to 150°. Since the bending angle of the curved structure 3215 relative to the axis of the connecting portion 323 is approximately the same as the angle between the vein of Marshall and the coronary sinus, in this way, the second catheter 30 can enter the blood vessel well without greatly Increase manufacturing cost.
  • the target tissue region as the human heart as an example, the operation steps of the ablation system 100A provided in the first embodiment for operating the human heart will be briefly described.
  • the first fluid includes gas or liquid
  • the second fluid is absolute ethanol. It can be understood that the present application does not limit the target tissue area to the human heart, for example, the lungs, kidneys or other target tissue areas of the living body.
  • the right femoral vein or subclavian vein is punctured, and the sheath is sent to the coronary sinus ostium of the right atrium through the inferior vena cava or superior vena cava.
  • Send the second catheter 30 which can be used instead of the guide wire, to the distal end of the Marshall vein along the lumen of the guiding catheter, and perform potential measurement.
  • the second catheter 30 With the first catheter 10 held proximal to the vein of Marshall, the second catheter 30 is used to perform potential measurements on the vein of Marshall. The ablation effect is judged according to the measurement results. When the ablation is unsuccessful, there is no need to withdraw the second catheter 30 , and the first catheter 10 can be directly used for re-ablation. After the ablation is completed, the second catheter 30 is retracted to the first catheter 10, and then the first catheter 10 and the second catheter 30 are retracted together to guide the catheter and the sheath to complete sheath retraction.
  • the ablation system 100A provided in this embodiment can measure the potential during ablation, monitor the intracardiac potential in real time and judge its ablation effect, which simplifies the ablation procedure, shortens the operation time, and improves the ablation efficiency.
  • an ablation system 100B provided in the second embodiment of the present application has substantially the same structure as the ablation system 100A provided in the first embodiment, except that the connecting tube 135 is located outside the flow channel 11 .
  • the distal end of the flow channel 11 includes a first area 116 , a second area 117 and a third area 118 arranged along the axial direction of the flow channel 11 , and the second area 117 is located between the first area 116 and the third area 118 . Between the third area 118 .
  • the first expandable element 131 is located in the first area 116
  • the second expandable element 133 is located in the third area 118 .
  • the second area 117 includes a first setting area 1171 and a second setting area 1173 .
  • the first setting area 1171 is used for setting the connecting pipe 135 .
  • the circulation channel 11 includes an inner tube 114 and an outer tube 115 sleeved outside the inner tube 114 . The distal end of the inner tube 114 emerges from the distal end of the outer tube 115 .
  • the connection tube 135 has a lumen 1350 .
  • There are multiple connecting pipes 135 and the multiple connecting pipes 135 are located in the first setting area 1171 of the second area 117 .
  • a plurality of connecting tubes 135 are arranged at intervals along the circumference of the inner tube 114 exposing the distal end of the outer tube 115 .
  • a gap 1353 is formed between two adjacent connecting pipes 135 corresponding to the second installation area 1173 .
  • the inner tube 114 is located outside the lumen 1350 of the connecting tube 135 .
  • the inner tube 114 passes through the first cavity of the first expandable component 131 and the second cavity of the second expandable component 131 .
  • the sidewall of the inner tube 114 is provided with an injection through hole 119 for injecting the second fluid.
  • the injection through hole 119 is located in the second setting area 1173 .
  • the spraying holes 119 are arranged corresponding to the positions of the gaps 1353 .
  • the cross-section of the connecting pipe 135 may be circular as shown in FIG. 17 , or may be fan-shaped.
  • the cross section of the connecting pipe 135 is substantially flat, and the connecting pipe 135 includes a first side wall 1355 , a second side wall 1356 , a third side wall 1357 and a fourth side wall. 1358.
  • the first side wall 1355 is opposite to the third side wall 1357 , and both the first side wall 1335 and the third side wall 1357 are arc-shaped walls.
  • the first side wall 1355 coincides with the outer wall of the inner tube 114 , so that the first side wall 1355 and the outer wall of the inner tube 114 can fit together well. It can be understood that, in some embodiments, at least part of the outer wall of the connecting tube 135 coincides with the outer wall of the inner tube 114 , so that the connecting tube 135 and the inner tube 114 can be better attached together.
  • the present application does not limit the structure of the flow pipe 11.
  • the flow pipe 11 can be a multi-lumen pipe, and the flow pipe 11 only needs to have a first fluid channel and a second fluid channel.
  • the connecting pipe 135 The number can be at least one, the connecting tube 135 is at least located in the second region 117 and the flow channel 11 is located outside the lumen 1350 of all the connecting tubes 135, and the flow channel 11 is passed through the first cavity and the second cavity of the first expandable member 131.
  • the second bladder of the expandable member 133 is a multi-lumen pipe, and the flow pipe 11 only needs to have a first fluid channel and a second fluid channel.
  • the connecting pipe 135 The number can be at least one, the connecting tube 135 is at least located in the second region 117 and the flow channel 11 is located outside the lumen 1350 of all the connecting tubes 135, and the flow channel 11 is passed through the first cavity and the second cavity of the first expandable member 131.
  • the second bladder of the expandable member 133 The second
  • the number of connecting pipes 135 is at least two, at least two connecting pipes 135 are arranged at intervals along the circumferential direction of the flow pipe 11, and along the circumferential direction of the flow pipe 11, adjacent two connecting pipes 135 are connected A gap 1353 is formed between the tubes 135 , and the position of the flow pipe 11 corresponding to the gap 1353 is provided with an injection through hole 119 .
  • the number of spray through holes 119 is the same as the number of connecting pipes 135 .
  • the side wall of the second fluid channel 113 of the flow pipe 11 is provided with an injection through hole 119 .
  • the first expandable member 131 and the second expandable member 133 are connected through at least one connecting tube 135, so that the structural section of the flow channel 11 provided with the injection through hole 119 does not need to be connected with the connecting tube 135.
  • the sealing process in this way, facilitates the construction and manufacture of the ablation system 100B.
  • an ablation system 100C provided in the third embodiment of the present application has substantially the same structure as the ablation system 100A provided in the first embodiment, except that the first catheter 10 omits the connecting tube 135 .
  • the distal end of the flow channel 11 includes a first area 116 , a second area 117 and a third area 118 arranged along the axial direction of the flow channel 11 .
  • the second area 117 is located between the first area 116 and the third area 118 .
  • the first expandable element 131 is located in the first area 116
  • the second expandable element 133 is located in the third area 118 .
  • the second area 117 includes a first setting area 1171 and a second setting area 1173 .
  • the expandable member 13 further includes an air guiding portion 137 covering the first setting area 1171 for communicating with the first expandable part 131 and the second expandable part 133 .
  • the distal end of the air guide part 137 is fixedly connected to the proximal end of the first expandable part 131
  • the proximal end of the air guide part 137 is fixedly connected to the distal end of the second expandable part 133 .
  • the air guide part 137 has an air guide channel 1371 communicating with the first cavity of the first expansion part 131 and the second cavity of the second expansion part 133 .
  • the second installation area 1173 is exposed outside the air guiding part 137 .
  • the inner tube 114 passes through the side wall of the second fluid passage 113 to form an injection hole 119 for injecting the second fluid in the second installation area 1173 .
  • the distance between the injection through hole 119 and the center of the first expandable part 131 is roughly half of the distance between the center of the first expandable part 131 and the center of the second expandable part 133 .
  • the first expandable part 131 and the second expandable part 133 are integrally formed, and since there is no connecting pipe, the structure is simple and the manufacturing process is simple.
  • the structure of the flow pipe 11 is not limited.
  • the side wall of the second fluid channel 113 of the flow pipe 11 forms an injection channel for spraying the second fluid in the second setting area 1173. Hole 119.
  • an ablation system 100D provided by the fourth embodiment of the present application is substantially the same in structure as the ablation system 100A provided by the first embodiment, except that the flow channel 11 is a multi-lumen channel.
  • the circulation channel 11 includes a first fluid channel 111, a second fluid channel 113 and a receiving chamber 121, the first fluid channel 111 and the second fluid channel 113 are isolated from each other, the receiving cavity 121 is isolated from the first fluid channel 111, and the receiving cavity 121 is isolated from the second fluid channel 113 , and the second conduit 30 passes through the receiving cavity 121 .
  • the cross-sectional shape of the circulation channel 11 is approximately circular
  • the cross-sectional shape of the storage cavity 121 is approximately circular.
  • the receiving cavity 121 is located between the first fluid channel 111 and the second fluid channel 113, the sectional area of the receiving cavity 121 is larger than the sectional area of the first fluid channel 111, the sectional area of the receiving cavity 121 is larger than the sectional area of the second fluid channel 113, So that the movement space of the second conduit 30 in the receiving cavity 121 is sufficient.
  • the second conduit 30 Since the second conduit 30 is installed in the independent accommodation cavity 121, when the second conduit 30 moves relative to the flow conduit 11, it will not be disturbed by the second fluid, which is beneficial to improve the smoothness of the movement of the second conduit 30 relative to the flow conduit 11 .
  • the present application does not limit the cross-sectional shape of the circulation channel 11 , the cross-sectional shape of the receiving chamber 121 , the cross-sectional shape of the first fluid channel 111 , and the cross-sectional shape of the second fluid channel 113 .
  • an ablation system 100E provided by the fifth embodiment of the present application is substantially the same in structure as the ablation system 100A provided by the first embodiment, and the expandable member 13 also includes a third expandable member 139 , the first The three expandable elements 139 have a third cavity 1390 , and the third cavity 1390 communicates with the first cavity 1310 and the second cavity 1330 .
  • the proximal end of the first expandable element 131 and the distal end of the second expandable element 133 are connected and communicated through a connecting tube 135, and the proximal end of the second expandable element 133 is connected to the third expandable element.
  • the distal end of the third expandable element 139 is connected and communicated with by a connecting tube 135 , and the proximal end of the third expandable element 139 is fixedly connected with the distal end of the outer tube 115 .
  • the connecting tube 135 between the proximal end of the first expandable part 131 and the distal end of the second expandable part 133, the connecting tube between the distal end of the second expandable part 133 and the distal end of the third expandable part 139 135 are provided with breaches 1351, the inner tube 114 runs through the side wall of the second fluid passage 113 and is provided with injection through holes 119 for injecting the second fluid, and the positions of the injection through holes 119 correspond to the positions of the breaches 1351.
  • the inner wall of the lumen of the connecting tube 135 includes a first sealing area, and the first sealing area is arranged around the periphery of the opening 1351 .
  • the flow pipe 11 is provided with a second sealing area around the injection through hole 119 .
  • the first sealing area is in sealing connection with the second sealing area, so as to ensure the sealing connection between the edge of the opening 1351 and the inner tube 114 .
  • the first sealing area and the second sealing area may be sealed and connected by heat fusion or the like, so that the edge of the breach 1351 is sealed and connected with the inner tube 114 .
  • the ablation system 100E provided by the fifth embodiment of the present application has three expandable components to adapt to organisms with relatively long blood vessels. For example, because some patients may have longer veins of Marshall, two expandable components cannot achieve one-time occlusion and ablation, and three expandable components with longer lengths can effectively occlude.
  • the structure of the flow channel 11 is not limited.
  • the expandable member 13 of multi-expansion element type is also applicable.
  • the present application does not limit the position of the third expandable part 139 , for example, the third expandable part 139 may be connected between the first expandable part 131 and the second expandable part 133 .
  • the expandable member 13 may also include a fourth expansion member, a fifth expansion member, . . . and so on.
  • an ablation system 100F provided in the sixth embodiment of the present application is substantially the same in structure as the ablation system 100A provided in the first embodiment, except that the structure of the first catheter 10 is different.
  • the ablation system 100F includes a first catheter 10 and a second catheter 30 .
  • the first catheter 10 is used to ablate a target tissue region.
  • the first catheter 10 includes a flow conduit 11 and an expandable member 13 .
  • the flow channel 11 includes a first fluid channel 111 and a second fluid channel 113 which are isolated from each other.
  • the expandable member 13 is sheathed on the flow channel 11 .
  • the first fluid channel 111 is used to provide the first fluid to the expandable member 13 to expand the expandable member 13 to achieve occlusion of blood vessels.
  • the second fluid channel 113 is used to provide a second fluid for ablation to the target tissue area.
  • the second conduit 30 is passed through the flow conduit 11 , and the second conduit 30 is exposed from the distal end of the flow conduit 11 for potential mapping.
  • the distal end of the second catheter 30 can simultaneously perform potential mapping.
  • Real-time monitoring of intracardiac potential and can judge the ablation effect according to the real-time monitored intracardiac potential, so as to achieve the purpose of good treatment.
  • the ablation system 100F in this embodiment can perform intracardiac potential while ablation Measurement does not require separate operations for ablation and mapping, which greatly simplifies the operation steps and shortens the operation time.
  • the flow channel 11 includes an inner tube 114 and an outer tube 115 .
  • the inner tube 114 passes through the outer tube 115 .
  • the outer wall of the inner tube 114 and the inner wall of the outer tube 113 jointly enclose the first fluid channel 111 .
  • the distal end of the first fluid channel 111 is closed.
  • the inner tube 114 is provided with a second fluid passage 113 .
  • the second conduit 30 passes through the second fluid channel 113 .
  • the proximal end of the second conduit 30 exposes the proximal end of the inner tube 114
  • the distal end of the second conduit 30 exposes the distal end of the inner tube 114 .
  • the expandable member 13 is sheathed on the inner tube 114 , and the proximal end of the expandable member 13 is fixedly connected with the distal end of the outer tube 115 and communicated with the first fluid channel 111 .
  • the specific structure, material, etc. of the inner tube 114 and the specific structure, material, etc. of the outer tube 115 can refer to the first embodiment of the present application.
  • the expandable member 13 includes a first expandable part 131 and a second expandable part 133 disposed along the axial direction of the flow channel 11 .
  • the first expandable part 131 is fixedly connected with the second expandable part 133 .
  • the first expandable member 131 has a first bladder 1310
  • the second expandable member 133 has a second bladder 1330 .
  • the first cavity 1310 communicates with the second cavity 1330
  • the second cavity 1330 communicates with the first fluid channel 111 .
  • the first fluid channel 111 is used to input the first fluid into the first cavity 1310 and the second cavity 1330 .
  • the distal end of the inner tube 114 passes through the second cavity 1330 of the second expandable element 133 and the first cavity 1310 of the first expandable element 131 in turn.
  • the distal end of the outer tube 115 is fixedly connected to the proximal end of the second expandable member 133 .
  • the first expandable part 131 and the second expandable part 133 are integrally arranged, and no connecting pipe is provided between the first expandable part 131 and the second expandable part 133 of the first catheter 10, so as to simplify the structure of the expandable member 13, And the manufacture of the expandable member 13 is facilitated.
  • the first developing object 141 is located at the position of the inner tube 114 corresponding to the first expandable member 131 , so as to mark the position of the first expandable member 131 when the ablation system 100F performs an operation.
  • the second developing object 143 is located at the position of the inner tube 114 corresponding to the second expandable member 133, so as to mark the position of the second expandable member 133 when the ablation system 100F performs an operation.
  • Both the first developing object 141 and the second developing object 143 are made of X-ray opaque material.
  • the head end 15 includes a hollow cavity 150 communicating with the second fluid channel 113 for injecting the second fluid.
  • the distal peripheral wall of the head end 15 is not provided with injection ports to simplify the structure of the head end 15 .
  • the first conduit 10 further includes a connector 58, the connector 58 is sleeved on the outer tube 115 and the inner tube 114 of the flow channel 11, for providing the first fluid to the first fluid channel 111 and to the first fluid channel 111.
  • the second fluid channel 113 provides a second fluid.
  • the connector 58 includes a base body 581 , a first injection tube 583 and a second injection tube 585 .
  • the seat body 581 is sheathed on the outer tube 115 .
  • the seat body 581 defines a first installation hole 5810 and a second installation hole 5811 in communication with each other along the axial direction.
  • the first installation hole 5810 runs through the distal end surface of the seat body 581.
  • the diameter of the first installation hole 5811 is larger than the diameter of the second installation hole 5811 . It can be understood that the diameter of the first installation hole 5811 and the diameter of the second installation hole 5811 may be the same or different.
  • a first dispensing hole 5813 and a second dispensing hole 5814 are disposed on the outer wall of the base body 581 . Compared with the first glue dispensing hole 5813 , the second glue dispensing hole 5814 is closer to the proximal end of the seat body 581 .
  • the first glue dispensing hole 5813 communicates with the first installation hole 5810
  • the second glue dispensing hole 5814 communicates with the second installation hole 5811 .
  • Both the inner tube 114 and the outer tube 115 pass through the first installation hole 5810 .
  • the proximal end of the inner tube 114 exposes the proximal end of the outer tube 115 and passes through the second installation hole 5811 .
  • the colloid can be loaded from the first dispensing hole 5813 and the second dispensing hole 5814, so that the proximal end of the outer tube 115 is fixed to the seat body 581, and the proximal end of the inner tube 114 is connected to the seat body 581. phase fixed.
  • the application does not limit the connection method between the seat body 581 and the outer tube 115 , and the application does not make limitations on the connection method between the seat body 581 and the inner tube 114 .
  • the first injection pipe 583 has a first fluid injection port 5831 for injecting the first fluid into the first fluid channel 111 .
  • the second injection pipe 585 has a second fluid injection port 5851 for injecting the second fluid into the second fluid channel 113 .
  • the first fluid injection port 5831 and the second fluid injection port 5851 are disposed on the same seat body 581 , which can simplify the structure of the connector 58 and facilitate the assembly of the ablation system 100F.
  • the proximal surface of the base body 581 is further provided with a flaring opening 5817 communicating with the second installation hole 5811 .
  • the first conduit 10 also includes a gasket 58 .
  • the sealing gasket 58 is accommodated in the flared opening 5817 and sealed with the seat body 581 to prevent blood and the second fluid from overflowing.
  • the outer diameter of the gasket 18 can be slightly larger than the diameter of the flaring 5817.
  • the gasket 18 is provided with a second insertion hole 181 .
  • the material of the gasket 18 includes but is not limited to silica gel.
  • the second conduit 30 passes through the second installation hole 5811 and the second insertion hole 181 of the gasket 18 .
  • the first catheter 10 further includes a tail cap 62 fixedly connected to the proximal end of the seat body 581 .
  • the tail cover 62 includes a sleeve portion 621 and a joint portion 623 accommodated in the sleeve portion 621 .
  • a proximal end of the engaging portion 623 is fixedly connected to a proximal end of the sleeve portion 621 .
  • a catheter hole 6210 is formed on the proximal surface of the sheathing portion 621 , and the catheter hole 6210 passes through the proximal surface of the joint portion 623 and the distal surface of the joint portion 623 .
  • the second conduit 30 passes through the conduit hole 6210 .
  • an external thread 5819 is provided on the outer wall of the proximal end of the seat body 581, and an internal thread 6213 matching the external thread 5819 is provided on the inner wall of the sleeve part 621.
  • the internal thread 6213 is screwed.
  • the proximal end of the base body 581 is sandwiched between the sleeve portion 621 and the joint portion 623, so that the base body 581 is limited between the sleeve portion 621 and the joint portion 623 and is difficult to move in the radial direction, thereby The stability of the ablation system 100F can be improved.
  • the connector 58 further includes a sheath 60 sheathed on the distal end of the base body 581 , and the flow channel 11 is passed through the sheath 60 .
  • the sheath 60 is used to protect the flow pipe 11 and improve the strength of the flow pipe 11 to reduce the possibility of the flow pipe 11 being damaged due to bending.
  • both the inner tube 114 and the outer tube 115 are passed through the sheath 60 .
  • the proximal end of the sheath 60 is in interference fit with the seat body 581, and the distal end of the sheath 60 is in clearance fit with the flow channel 11 (such as the outer tube 115).
  • the sheath 60 can be made of silica gel, rubber, TPU, Pebax materials with relatively low hardness. Rubber is preferred for this embodiment.
  • the connectors in the ablation system 100F are split, for example, the connectors in the first embodiment of the present application include a first connector and a second connector, and the distal end of the first connector can be sleeved with The sheath, and/or the distal end of the second connector can be covered with a sheath.
  • the structure of the flow pipe 11 is not limited.
  • the flow pipe 11 is a multi-lumen pipe
  • the integrated connector 58 is also applicable, and the flow pipe 11 only needs to have a first fluid channel and a second fluid channel.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Otolaryngology (AREA)
  • Plasma & Fusion (AREA)
  • Physiology (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

An ablation system (100A), comprising a first catheter (10) and a second catheter (30). The first catheter (10) comprises a circulation conduit (11) and an expandable member (13). The circulation conduit (11) comprises a first fluid channel (111) and a second fluid channel (113) isolated from each other. The expandable member (13) is sleeved on the circulation conduit (11). The first fluid channel (111) is used for providing a first fluid to the expandable member (13) to expand the expandable member (13). The second fluid channel (113) is used for providing a second fluid for ablation to a target tissue region. The second catheter (30) passes through the circulation conduit (11), and the second catheter (30) is exposed from the distal end of the circulation conduit (11) for potential mapping. When the second fluid is provided through the second fluid channel (113) of the first catheter (10) to ablate the target tissue region, the distal end of the second catheter (30) can perform potential mapping at the same time, thereby realizing real-time monitoring of the intracardiac potential during the ablation process, greatly simplifying the operation steps, shortening the operation time; therefore, ablation treatment can be quickly performed.

Description

消融系统Ablation system
本申请要求提交中国国家知识产权局、申请号为202111406405.1(申请名称为“消融系统”)的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application claims the priority of a Chinese patent application with application number 202111406405.1 (application title "Ablation System") filed with the State Intellectual Property Office of China, the entire contents of which are incorporated herein by reference.
技术领域technical field
本申请涉及医疗器械技术领域,特别涉及一种消融系统。The present application relates to the technical field of medical devices, in particular to an ablation system.
背景技术Background technique
研究表明,Marshall束及神经均是部分房性心律失常的触发灶,是心房颤动的发病机制之一。尽管Marshall静脉的尺寸很小且很难用常规导管进行射频或者脉冲消融,但多项研究证实,通过Marshall静脉逆行酒精注射可以终止房颤。Studies have shown that both the Marshall bundle and nerves are the trigger foci of some atrial arrhythmias, which is one of the pathogenesis of atrial fibrillation. Despite the small size of the Marshall vein and the difficulty of radiofrequency or pulse ablation with conventional catheters, several studies have demonstrated that retrograde alcohol injection through the Marshall vein can terminate AF.
然而,目前通过Marshall静脉逆行酒精注射治疗房颤时,心内电位测定的操作相当繁琐,导致不能简便快速地进行Marshall静脉的化学消融治疗。However, at present, when retrograde alcohol injection is used to treat atrial fibrillation through the Marshall vein, the operation of intracardiac potential measurement is quite cumbersome, which makes it impossible to perform simple and rapid chemical ablation of the Marshall vein.
发明内容Contents of the invention
为了实现上述目的,本申请实施方式采用如下技术方案:In order to achieve the above purpose, the implementation mode of this application adopts the following technical solutions:
本申请提供一种消融系统,包括第一导管与第二导管。所述第一导管包括流通管道和可膨胀构件,所述流通管道包括相互隔离的第一流体通道及第二流体通道;所述可膨胀构件套设于所述流通管道上,所述第一流体通道用于向所述可膨胀构件提供第一流体以使所述可膨胀构件膨胀;所述第二流体通道用于向目标组织区域提供用于消融的第二流体;所述第二导管穿设于所述流通管道,所述第二导管从所述流通管道的远端露出用于进行电位标测。The present application provides an ablation system, including a first catheter and a second catheter. The first conduit includes a flow channel and an expandable member, the flow channel includes a first fluid channel and a second fluid channel isolated from each other; the expandable member is sleeved on the flow channel, the first fluid The channel is used to provide a first fluid to the expandable member to expand the expandable member; the second fluid channel is used to provide a second fluid for ablation to the target tissue area; the second catheter is passed through In the flow conduit, the second conduit is exposed from the distal end of the flow conduit for potential mapping.
本申请提供的消融系统,在通过第一导管的第二流体通道提供第二流体对目标组织区域进行消融时,第二导管的远端可同时进行电位标测,实现了在消融过程中对心内电位的实时监测,并能够根据实时监测到的心内电位判断消融效果,从而达到良好的治疗目的。在根据心内电位判断出消融效果不佳时,可直接通过第一导管进行再次消融,以及通过第二导管的远端同步进行电位标测。相比于相关方案中消融和标测只能分开操作(相应地,消融或标测作用的导管需分别送入及撤出体内),本申请提供的消融系统可在消融的同时进行心内电位测定,大幅简化了手术步骤,缩短了手术时间,能够快速进行消融治疗,同时能够根据监测到的心内电位判断消融效果,保证了消融效果,能够达到良好的治疗目的。In the ablation system provided by the present application, when the second fluid is provided through the second fluid channel of the first catheter to ablate the target tissue area, the distal end of the second catheter can perform potential mapping at the same time, which realizes centering during the ablation process. Real-time monitoring of the internal potential, and can judge the ablation effect according to the real-time monitoring of the intracardiac potential, so as to achieve a good therapeutic purpose. When it is judged that the ablation effect is not good according to the intracardiac potential, re-ablation can be performed directly through the first catheter, and potential mapping can be performed synchronously through the distal end of the second catheter. Compared with related schemes where ablation and mapping can only be performed separately (correspondingly, catheters for ablation or mapping need to be fed into and withdrawn from the body separately), the ablation system provided by this application can perform intracardiac potential while ablation The measurement greatly simplifies the operation steps, shortens the operation time, can perform ablation treatment quickly, and can judge the ablation effect according to the monitored intracardiac potential, guarantees the ablation effect, and can achieve a good therapeutic purpose.
附图说明Description of drawings
为了更清楚地说明本申请实施方式或现有技术中的技术方案,下面将对实施方式或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本申请的一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the technical solutions in the embodiments of the present application or the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the drawings in the following description are only These are some implementations of the present application. For those skilled in the art, other drawings can also be obtained according to these drawings without creative work.
图1为本申请第一实施方式提供的消融系统的示意图。Fig. 1 is a schematic diagram of an ablation system provided in the first embodiment of the present application.
图2为图1所示的消融系统去除第二导管的示意图。FIG. 2 is a schematic diagram of removing a second catheter by the ablation system shown in FIG. 1 .
图3为流通管道的内管与外管的截面示意图。Fig. 3 is a schematic cross-sectional view of the inner tube and the outer tube of the flow channel.
图4为第一导管的远端示意图。Figure 4 is a schematic view of the distal end of the first catheter.
图5为图4的局部区域放大示意图。FIG. 5 is an enlarged schematic diagram of a local area of FIG. 4 .
图6为图5所示结构沿线A-A的截面示意图。FIG. 6 is a schematic cross-sectional view of the structure shown in FIG. 5 along the line A-A.
图7为图4所示的第一导管的远端部分区域的放大示意图。FIG. 7 is an enlarged schematic view of the region of the distal portion of the first catheter shown in FIG. 4 .
图8为第二管体、密封垫、尾盖、第二导管的组装示意图。Fig. 8 is a schematic diagram of the assembly of the second pipe body, the sealing gasket, the tail cap and the second conduit.
图9为第二导管的示意图。Figure 9 is a schematic diagram of a second catheter.
图10、图11、图12为承载部在其他一些实施方式中的可能结构示意图。Fig. 10, Fig. 11 and Fig. 12 are schematic diagrams of possible structures of the bearing part in some other embodiments.
图13为本申请第二实施方式提供的一种消融系统的示意图。Fig. 13 is a schematic diagram of an ablation system provided in the second embodiment of the present application.
图14为图13所示的消融系统去除第二导管的示意图。FIG. 14 is a schematic diagram of removing the second catheter by the ablation system shown in FIG. 13 .
图15为图14所示的消融系统的部分区域放大示意图。FIG. 15 is an enlarged schematic diagram of a partial area of the ablation system shown in FIG. 14 .
图16为图15所示结构沿线B-B的截面示意图。FIG. 16 is a schematic cross-sectional view of the structure shown in FIG. 15 along line B-B.
图17为本申请一实施方式中的连接管与内管组装于一起的示意图。Fig. 17 is a schematic diagram of the assembly of the connecting pipe and the inner pipe in one embodiment of the present application.
图18为本申请第三实施方式提供的一种消融系统的示意图。Fig. 18 is a schematic diagram of an ablation system provided in the third embodiment of the present application.
图19为图18所示的消融系统去除第二导管的示意图。Fig. 19 is a schematic diagram of removing the second catheter by the ablation system shown in Fig. 18 .
图20为图19所示的消融系统的部分区域放大示意图。FIG. 20 is an enlarged schematic diagram of a partial area of the ablation system shown in FIG. 19 .
图21为图20所示结构沿线C-C的截面示意图。FIG. 21 is a schematic cross-sectional view of the structure shown in FIG. 20 along line C-C.
图22为本申请第四实施方式提供的一种消融系统的示意图。Fig. 22 is a schematic diagram of an ablation system provided in a fourth embodiment of the present application.
图23为图22所示结构沿线D-D的截面示意图。FIG. 23 is a schematic cross-sectional view of the structure shown in FIG. 22 along line D-D.
图24为本申请第五实施方式提供的一种消融系统的示意图。Fig. 24 is a schematic diagram of an ablation system provided in a fifth embodiment of the present application.
图25为图24所示的消融系统的部分区域放大示意图。FIG. 25 is an enlarged schematic diagram of a partial area of the ablation system shown in FIG. 24 .
图26为本申请第六实施方式提供的一种消融系统的示意图。Fig. 26 is a schematic diagram of an ablation system provided in the sixth embodiment of the present application.
图27为图26所示的消融系统的流通管道的剖面示意图。FIG. 27 is a schematic cross-sectional view of the flow channel of the ablation system shown in FIG. 26 .
图28为图26所示的消融系统的部分区域放大示意图。FIG. 28 is an enlarged schematic diagram of a partial area of the ablation system shown in FIG. 26 .
图29为图26所示的消融系统的第一导管的示意图。FIG. 29 is a schematic diagram of the first catheter of the ablation system shown in FIG. 26 .
具体实施方式Detailed ways
下面将结合本申请实施方式中的附图,对本申请实施方式中的技术方案进行清楚、完整地描述,显然,所描述的实施方式仅仅是本申请一部分实施方式,而不是全部的实施方式。基于本申请中的实施方式,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施方式,都属于本申请保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the application with reference to the accompanying drawings in the embodiments of the application. Apparently, the described embodiments are only part of the embodiments of the application, not all of them. Based on the implementation manners in this application, all other implementation manners obtained by persons of ordinary skill in the art without creative efforts shall fall within the scope of protection of this application.
以下各实施例的说明是参考附加的图示,用以例示本发明可用以实施的特定实施例。本发明中所提到的方向用语,例如,“上”、“下”、“前”、“后”、“左”、“右”、“内”、“外”、“侧面”等,仅是参考附加图式的方向,因此,使用的方向用语是为了更好、更清楚地说明及理解本发明,而不是指示或暗指所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。The following descriptions of the various embodiments refer to the accompanying drawings to illustrate specific embodiments in which the invention may be practiced. The directional terms mentioned in the present invention, for example, "upper", "lower", "front", "back", "left", "right", "inner", "outer", "side", etc., only is to refer to the direction of the attached drawings. Therefore, the direction terms used are for better and more clearly explaining and understanding the present invention, rather than indicating or implying that the device or element referred to must have a specific orientation, use a specific orientation construction and operation, therefore, should not be construed as limiting the invention.
此外,本文中为部件所编序号本身,例如“第一”、“第二”等,仅用于区分所描述的对象,不具有任何顺序或技术含义。而本申请所说“连接”、“联接”,如无特别说明,均包括直接和间接连接(联接)。In addition, the serial numbers assigned to components herein, such as "first", "second", etc., are only used to distinguish the described objects, and do not have any sequence or technical meaning. The "connection" and "connection" mentioned in this application all include direct and indirect connection (connection) unless otherwise specified.
在介入医疗器械技术领域,一般将靠近操作者的方位定义为近端,远离操作者的方位定义为远端;将柱体、管体等一类物体的旋转中心轴的方向定义为轴向,与轴向垂直的方向定义为径向。该等定义,只是为了表述方便,并不构成对本申请的限制。In the field of interventional medical device technology, the orientation close to the operator is generally defined as the proximal end, and the orientation away from the operator is defined as the distal end; the direction of the rotation center axis of objects such as cylinders and tubes is defined as the axial direction, A direction perpendicular to the axial direction is defined as a radial direction. These definitions are only for the convenience of expression and do not constitute a limitation to the present application.
请参阅图1与图2,本申请第一实施方式提供一种消融系统100A,用于通过化学消融治疗的方式对目标组织区域进行消融,达到电隔离的效果,且可以在消融的同时进行心内电位测定。目标组织区域可以位于心脏,包括但不限于Marshall静脉。可以理解,目标组织区域不限定位于心脏,也可以位于其他机体组织上,在此不作限定。Please refer to FIG. 1 and FIG. 2. The first embodiment of the present application provides an ablation system 100A, which is used to ablate the target tissue area by means of chemical ablation therapy to achieve the effect of electrical isolation, and can perform cardiac ablation at the same time. Internal potential measurement. The target tissue area can be located in the heart, including but not limited to the vein of Marshall. It can be understood that the target tissue area is not limited to be located on the heart, but may also be located on other body tissues, which is not limited here.
消融系统100A包括第一导管10与第二导管30。第一导管10用于对目标组织区域进行消融。第一导管10包括流通管道11和可膨胀构件13。请结合参阅图3,流通管道11包括相互隔离的第一流体通道111及第二流体通道113。可膨胀构件13套设于流通管道11上。第一流体通道111用于向可膨胀构件13提供第一流体以使可膨胀构件13膨胀,实现对血管进行封堵。第二流体通道113用于向目标组织区域提供用于消融的第二流体。第二导管30穿设于流通管道11,第二导管30从流通管道11的远端露出用于进行电位标测。The ablation system 100A includes a first catheter 10 and a second catheter 30 . The first catheter 10 is used to ablate a target tissue region. The first catheter 10 includes a flow conduit 11 and an expandable member 13 . Please refer to FIG. 3 , the flow channel 11 includes a first fluid channel 111 and a second fluid channel 113 which are isolated from each other. The expandable member 13 is sheathed on the flow channel 11 . The first fluid channel 111 is used to provide the first fluid to the expandable member 13 to expand the expandable member 13 to achieve occlusion of blood vessels. The second fluid channel 113 is used to provide a second fluid for ablation to the target tissue area. The second conduit 30 is passed through the flow conduit 11 , and the second conduit 30 is exposed from the distal end of the flow conduit 11 for potential mapping.
消融系统100A在通过第一导管10的第二流体通道113提供第二流体对目标组织区域进行消融时,第二导管30的远端可同时进行电位标测,一方面实现了在消融过程中对心内电位的实时监测,并能够根据实时监测到的心内电位判断消融效果,从而达到良好的治疗的目的,另一方面,本实施方式中的消融系统100A可在消融的同时进行心内电位测定,无需将消融和标测分开操作,因而大幅简化了手术步骤,缩短了手术时间。When the ablation system 100A provides the second fluid through the second fluid channel 113 of the first catheter 10 to ablate the target tissue area, the distal end of the second catheter 30 can simultaneously perform potential mapping. Real-time monitoring of intracardiac potential, and can judge the ablation effect according to the real-time monitoring of intracardiac potential, so as to achieve the purpose of good treatment. On the other hand, the ablation system 100A in this embodiment can perform intracardiac potential Measurement does not require separate operations for ablation and mapping, which greatly simplifies the operation steps and shortens the operation time.
流通管道11包括内管114与外管115。内管114穿设于外管115。内管114的外壁与外管113的内壁共同围成第一流体通道111。第一流体通道111的远端封闭。内管114设有第二流体通道113。第二导管30穿设于第二流体通道113。第二导管30的近端露出内管114的近端,第二导管30的远端露出内管114的远端。可膨胀构件13套设于内管114上,可膨胀构件13的近端与外管115的远端固定连接并与第一流体通道111连通。The flow channel 11 includes an inner tube 114 and an outer tube 115 . The inner tube 114 passes through the outer tube 115 . The outer wall of the inner tube 114 and the inner wall of the outer tube 113 jointly enclose the first fluid channel 111 . The distal end of the first fluid channel 111 is closed. The inner tube 114 is provided with a second fluid passage 113 . The second conduit 30 passes through the second fluid channel 113 . The proximal end of the second conduit 30 exposes the proximal end of the inner tube 114 , and the distal end of the second conduit 30 exposes the distal end of the inner tube 114 . The expandable member 13 is sheathed on the inner tube 114 , and the proximal end of the expandable member 13 is fixedly connected with the distal end of the outer tube 115 and communicated with the first fluid channel 111 .
内管114与外管115为同轴设置,内管114的远端露出外管115的远端。内管114与外管115的材质为尼龙(polyamide,PA)。可以理解,在其他实施方式中,内管114与外管115可以不同轴设置,本申请亦不限定内管114与外管115的材质。The inner tube 114 and the outer tube 115 are arranged coaxially, and the distal end of the inner tube 114 exposes the distal end of the outer tube 115 . The inner tube 114 and the outer tube 115 are made of nylon (polyamide, PA). It can be understood that, in other embodiments, the inner tube 114 and the outer tube 115 may not be arranged coaxially, and the application does not limit the materials of the inner tube 114 and the outer tube 115 .
本实施方式中,内管114的内径范围为0.55mm-1.40mm,外管115的内径范围为0.85mm-1.70mm,例如,内管114的内径为0.70mm,外管115的内径为1.20mm。可以理解,本申请不限定内管114的内径范围,本申请不限定外管115的内径范围。In this embodiment, the inner diameter of the inner tube 114 ranges from 0.55 mm to 1.40 mm, and the inner diameter of the outer tube 115 ranges from 0.85 mm to 1.70 mm. For example, the inner diameter of the inner tube 114 is 0.70 mm, and the inner diameter of the outer tube 115 is 1.20 mm. . It can be understood that the application does not limit the inner diameter range of the inner tube 114 , and the application does not limit the inner diameter range of the outer tube 115 .
进一步,可选地,可膨胀构件13包括沿流通管道11的轴向设置的第一可膨胀件131及第二可膨胀件133。第一可膨胀件131与第二可膨胀件133固定连接。第一可膨胀件131与第二可膨胀件133沿流通管道11的轴向呈串联型结构,以提高可膨胀构件13对血管进行封堵的效果。Further, optionally, the expandable member 13 includes a first expandable part 131 and a second expandable part 133 arranged along the axial direction of the flow channel 11 . The first expandable part 131 is fixedly connected with the second expandable part 133 . The first expandable member 131 and the second expandable member 133 are arranged in series along the axial direction of the flow channel 11 to improve the effect of the expandable member 13 on blood vessel occlusion.
具体地,第一可膨胀件131具有第一囊腔1310(如图4所示),第二可膨胀件133具有第二囊腔1330(如图4所示)。第一囊腔1310与第二囊腔1330连通,第二囊腔1330与第一流体通道111连通。换而言之,第一流体通道111用于向第一囊腔1310与第二囊腔1330输入第一流体。内管114的远端依次穿设于第二可膨胀件133的第二囊腔1330及第一可膨胀件131的第一囊腔1310。外管115的远端与第二可膨胀件133的近端固定连接。Specifically, the first expandable element 131 has a first cavity 1310 (as shown in FIG. 4 ), and the second expandable element 133 has a second cavity 1330 (as shown in FIG. 4 ). The first cavity 1310 communicates with the second cavity 1330 , and the second cavity 1330 communicates with the first fluid channel 111 . In other words, the first fluid channel 111 is used to input the first fluid into the first cavity 1310 and the second cavity 1330 . The distal end of the inner tube 114 passes through the second cavity 1330 of the second expandable element 133 and the first cavity 1310 of the first expandable element 131 in turn. The distal end of the outer tube 115 is fixedly connected to the proximal end of the second expandable member 133 .
本实施方式中,第一可膨胀件131大致呈球囊状,第二可膨胀件133大致呈球囊状。第一可膨胀件131的中心与第二可膨胀件133的中心之间的距离范围为4mm-12mm,例如,第一可膨胀件131的中心与第二可膨胀件133的中心之间的距离为6mm。可选地,第一可膨胀件131与第二可膨胀件133均采用半顺应性球囊,以提升球囊的封堵效果。半顺应性球囊具有宽广的工作范围,可灵活的操纵球囊尺寸,多用于进行预扩张。第一可膨胀件131与第二可膨胀件133的材质包括聚醚嵌段聚酰胺(polyether block amide,PEBAX)、PA、热塑性聚氨 酯弹性体橡胶(thermoplastic polyurethanes,TPU)中的一种。可以理解,本申请对第一可膨胀件131与第二可膨胀件133的材质不作限定。In this embodiment, the first expandable member 131 is roughly in the shape of a balloon, and the second expandable member 133 is roughly in the shape of a balloon. The distance between the center of the first expandable part 131 and the center of the second expandable part 133 ranges from 4 mm to 12 mm, for example, the distance between the center of the first expandable part 131 and the center of the second expandable part 133 is 6mm. Optionally, both the first inflatable member 131 and the second inflatable member 133 are semi-compliant balloons, so as to improve the sealing effect of the balloons. Semi-compliant balloons have a wide working range, can flexibly manipulate the size of the balloon, and are mostly used for pre-dilation. The material of the first expandable member 131 and the second expandable member 133 includes one of polyether block amide (polyether block amide, PEBAX), PA, thermoplastic polyurethane elastomer rubber (thermoplastic polyurethanes, TPU). It can be understood that the present application does not limit the materials of the first expandable element 131 and the second expandable element 133 .
可膨胀构件13包括膨胀状态及非膨胀状态。可膨胀构件13通过第一流体通道111所提供的第一流体进行膨胀,以能够封堵血管。可膨胀构件13在膨胀状态下的体积大于可膨胀构件13在非膨胀状态下的体积。在膨胀状态下,第一可膨胀件131的形状、第二可膨胀件133的形状可以是如图4所示的具有中空的圆柱形状。如图4所示,第一可膨胀件131的轴向长度大于第一可膨胀件131的最大外径,第二可膨胀件133的轴向长度大于第二可膨胀件133的最大外径。The expandable member 13 includes an expanded state and a non-expanded state. The expandable member 13 is expanded by the first fluid provided by the first fluid channel 111 to be able to occlude the blood vessel. The volume of the expandable member 13 in the expanded state is larger than the volume of the expandable member 13 in the non-expanded state. In the expanded state, the shape of the first expandable part 131 and the shape of the second expandable part 133 may be a hollow cylindrical shape as shown in FIG. 4 . As shown in FIG. 4 , the axial length of the first expandable element 131 is greater than the maximum outer diameter of the first expandable element 131 , and the axial length of the second expandable element 133 is greater than the maximum outer diameter of the second expandable element 133 .
可以理解,本申请对第一可膨胀件131的形状不作限定,例如,可以为心形、方形、球形等。本申请对第二可膨胀件133的形状不作限定,例如,可以为心形、方形、球形等。It can be understood that the present application does not limit the shape of the first expandable member 131 , for example, it may be heart-shaped, square, spherical and so on. The present application does not limit the shape of the second expandable member 133 , for example, it may be heart-shaped, square, spherical and so on.
请结合图5与图6,可膨胀构件13还包括位于流通管道11外的连接管135,用于连接第一可膨胀件131与第二可膨胀件133。连接管135的远端与第一可膨胀件131的近端固定连接,连接管135的近端与第二可膨胀件133的远端固定连接。连接管135具有管腔1350,管腔1350连通第一囊腔1310与第二囊腔1330,从而使得输入至第二囊腔1330的第一流体经管腔1350进入第一囊腔1310。内管114的远端还穿设于管腔1350。Please refer to FIG. 5 and FIG. 6 , the expandable member 13 further includes a connecting pipe 135 outside the flow channel 11 for connecting the first expandable part 131 and the second expandable part 133 . The distal end of the connecting tube 135 is fixedly connected to the proximal end of the first expandable element 131 , and the proximal end of the connecting tube 135 is fixedly connected to the distal end of the second expandable element 133 . The connecting tube 135 has a lumen 1350 , and the lumen 1350 communicates with the first cavity 1310 and the second cavity 1330 , so that the first fluid input into the second cavity 1330 enters the first cavity 1310 through the lumen 1350 . The distal end of the inner tube 114 also passes through the lumen 1350 .
本实施方式中,通过激光焊接将连接管135与第一可膨胀件131的近端固定相接,通过激光焊接将连接管135与第二可膨胀件133的远端固定相接。可以理解,本申请不限定连接管135与第一可膨胀件131之间的固定连接方式,本申请不限定连接管135与第二可膨胀件133之间的固定连接方式。In this embodiment, the connecting tube 135 is fixedly connected to the proximal end of the first expandable member 131 by laser welding, and the connecting tube 135 is fixedly connected to the distal end of the second expandable member 133 by laser welding. It can be understood that the present application does not limit the fixed connection method between the connecting pipe 135 and the first expandable member 131 , and the present application does not limit the fixed connection method between the connecting pipe 135 and the second expandable member 133 .
本实施方式中,连接管135的轴向长度范围为不小于6mm,连接管135的内径与外管115的远端的外径大致相同,连接管135的材质与外管115的材质相同。可以理解,本申请不限定连接管135的长度,本申请不限定连接管135的外径尺寸与材质。In this embodiment, the axial length of the connecting pipe 135 is not less than 6 mm, the inner diameter of the connecting pipe 135 is approximately the same as the outer diameter of the distal end of the outer pipe 115 , and the material of the connecting pipe 135 is the same as that of the outer pipe 115 . It can be understood that the present application does not limit the length of the connecting pipe 135 , and the present application does not limit the outer diameter and material of the connecting pipe 135 .
进一步,在一种实施方式中,连接管135的管壁上设有破口1351,以露出部分内管114。破口1351大致呈矩形。可以理解,本申请对破口1351的形状不作具体限定,例如,可以是圆形、椭圆形、矩形、不规则形状等。流通管道11贯通内管114的侧壁设有用于喷射第二流体的喷射通孔119,喷射通孔119的位置对应破口1351的位置。喷射通孔119大致呈圆形。管腔1350的内壁包括第一密封区域1353,第一密封区域1353环绕破口1351的周沿设置。流通管道11环绕喷射通孔119设有第二密封区域1133。第一密封区域1353与第二密封区域1133密封连接,以确保破口1351的边缘与内管114之间密封连接。第一密封区域1353与第二密封区域1133可以通过热熔等方式进行密封连接。Further, in one embodiment, a breach 1351 is provided on the tube wall of the connecting tube 135 to expose part of the inner tube 114 . The breach 1351 is roughly rectangular. It can be understood that the present application does not specifically limit the shape of the opening 1351 , for example, it may be circular, oval, rectangular, or irregular. The flow pipe 11 passes through the side wall of the inner tube 114 to define an injection through hole 119 for injecting the second fluid, and the position of the injection through hole 119 corresponds to the position of the breach 1351 . The injection through hole 119 is substantially circular. The inner wall of the lumen 1350 includes a first sealing area 1353 disposed around the periphery of the breach 1351 . The flow pipe 11 is provided with a second sealing area 1133 around the injection hole 119 . The first sealing area 1353 is in sealing connection with the second sealing area 1133 to ensure the sealing connection between the edge of the opening 1351 and the inner tube 114 . The first sealing area 1353 and the second sealing area 1133 can be hermetically connected by heat fusion or the like.
可膨胀构件13采用串联型的双球囊结构,在对目标组织区域进行消融时,由于内管114的远端可以对目标组织区域的远端段喷射第二流体,喷射通孔119可以对目标组织区域的中间段以及近端段喷射第二流体,因此,无需多次对可膨胀构件13进行扩张、收缩、回撤等操作以完成对目标组织区域的远端段、中间段以及近端段的流体注射,只需对可膨胀构件13进行一次扩张及收缩即可完成对整个目标组织区域的第二流体的注射并消融。由此可见,可膨胀构件13采用串联型的双球囊结构之后,不仅可以实现边消融边标测,还可以仅通过一次操作完成对整个目标组织区域的消融,进一步更大程度上简化了手术步骤,缩短了手术时间,能够实现快速消融治疗。The expandable member 13 adopts a series-type double-balloon structure. When the target tissue area is ablated, since the distal end of the inner tube 114 can inject the second fluid to the distal end of the target tissue area, the injection through hole 119 can ablate the target tissue area. The middle section and the proximal section of the tissue area spray the second fluid, therefore, it is not necessary to perform operations such as expansion, contraction, and retraction on the expandable member 13 multiple times to complete the treatment of the distal section, the middle section, and the proximal section of the target tissue area. Injection of the fluid, only one expansion and contraction of the expandable member 13 is required to complete the injection and ablation of the second fluid to the entire target tissue area. It can be seen that after the inflatable member 13 adopts a series-type double-balloon structure, it can not only achieve simultaneous ablation and mapping, but also complete the ablation of the entire target tissue area with only one operation, which further simplifies the operation to a greater extent. The steps shorten the operation time and can realize rapid ablation treatment.
请再次参阅图4,第一导管10还包括第一显影物141与第二显影物143。第一显影物141位于内管114对应第一可膨胀件131的位置,以在消融系统100A实现手术时标记第一可膨胀件131的位置。第二显影物143位于内管114对应第二可膨胀件133的位置,以在消融系统 100A实现手术时标记第二可膨胀件133的位置。第一显影物141与第二显影物143均由不透X射线的材料制成。Please refer to FIG. 4 again, the first conduit 10 further includes a first developing object 141 and a second developing object 143 . The first developing object 141 is located at the position of the inner tube 114 corresponding to the first expandable member 131 , so as to mark the position of the first expandable member 131 when the ablation system 100A performs an operation. The second developing object 143 is located at the position of the inner tube 114 corresponding to the second expandable member 133, so as to mark the position of the second expandable member 133 when the ablation system 100A performs an operation. Both the first developing object 141 and the second developing object 143 are made of X-ray opaque material.
本实施方式中,第一显影物141、第二显影物143中的每一个设于内管114的外壁上并环绕内管114的周向设置进而形成环形的显影结构,第一显影物141大致设置于第一可膨胀件131的正中部,第二显影物143大致设置于第二可膨胀件133的正中部,从而通过第一显影物141与第二显影物143的显影即可确定手术过程中可膨胀件的位置,且该两个显影物围绕内管114呈环形布置,以提高显影效果。In this embodiment, each of the first developing object 141 and the second developing object 143 is arranged on the outer wall of the inner tube 114 and arranged around the circumference of the inner tube 114 to form a ring-shaped developing structure. The first developing object 141 is roughly Set in the middle of the first expandable part 131, the second developing object 143 is roughly arranged in the middle of the second expandable part 133, so that the operation process can be determined through the development of the first developing object 141 and the second developing object 143 The position of the inflatable member, and the two developers are arranged in a ring around the inner tube 114 to improve the developing effect.
可以理解,在其他实施方式中,第一显影物141可以位于第一可膨胀件131上,第二显影物143可以位于第二可膨胀件133上。It can be understood that, in other embodiments, the first developer 141 may be located on the first expandable member 131 , and the second developer 143 may be located on the second expandable member 133 .
请结合参阅图1、图2与图7,第一导管10还包括设置于内管114的远端的头端15。头端15的外径由头端15的近端向头端15的远端减小,例如,头端15大致呈锥台状,以提高第一导管10的跟踪性,及第一导管10进入血管的顺畅度。头端15包括与第二流体通道113连通的中空腔150。第二导管30穿设头端15并从头端15的远端露出。Please refer to FIG. 1 , FIG. 2 and FIG. 7 in conjunction, the first catheter 10 further includes a head end 15 disposed at a distal end of the inner tube 114 . The outer diameter of the head end 15 decreases from the proximal end of the head end 15 to the distal end of the head end 15. For example, the head end 15 is generally in the shape of a truncated cone to improve the tracking of the first catheter 10, and the first catheter 10 enters the blood vessel smoothness. The head end 15 includes a hollow cavity 150 in communication with the second fluid passage 113 . The second catheter 30 passes through the head end 15 and emerges from the distal end of the head end 15 .
本实施方式中,头端15的硬度大于内管114的硬度,以提高第一导管10进入狭窄的血管的顺畅度。头端15的轴向长度范围为1mm-3mm,例如头端15的轴向长度为2mm。可以理解,本申请对头端15的硬度及轴向长度不作限定。In this embodiment, the hardness of the head end 15 is greater than the hardness of the inner tube 114, so as to improve the smoothness of the first catheter 10 entering narrow blood vessels. The axial length of the head end 15 ranges from 1 mm to 3 mm, for example, the axial length of the head end 15 is 2 mm. It can be understood that the present application does not limit the hardness and axial length of the head end 15 .
由于短且硬的头端15可以使第一导管10更容易进入狭小的Marshall静脉,但因此也可能造成对血管的损伤,因此,可选地,在一种实施方式中,第一导管10可以包括涂覆于头端15的外壁的保护层(图未示)。保护层的材质较软,以减少头端15进入血管时对血管的损伤。本实施方式中,保护层的材质包括但不限定为聚四氟乙烯(poly tetra fluoro ethylene,PTFE)。Since the short and hard tip 15 can make the first catheter 10 easier to enter the narrow vein of Marshall, but it may also cause damage to the blood vessel, therefore, optionally, in one embodiment, the first catheter 10 can It includes a protective layer (not shown) coated on the outer wall of the head end 15 . The material of the protective layer is relatively soft, so as to reduce the damage to the blood vessel when the head end 15 enters the blood vessel. In this embodiment, the material of the protective layer includes but is not limited to polytetrafluoroethylene (polytetrafluoroethylene, PTFE).
可选地,头端15的远端周壁上设有与头端15的中空腔150连通的喷射口151。喷射口151用于喷射第二流体。中空腔150与喷射口151可同时喷射第二流体,以提高第二流体的喷射面积,进而提高消融效率。喷射口151的数量可以为一个或一个以上。喷射口151的数量为一个以上时,一个以上的喷射口151沿头端15的周向设置。可选地,中空腔150的内壁上形成台阶153。内管114的远端收容于中空腔150内并与台阶153相抵持。台阶153用于对头端15与内管114配合时进行限位,以增加头端15与内管114之间的连接稳定性。请再次参阅图1与图2,第一导管10还包括第一连接器16及第二连接器17。第一连接器16固定套设于流通管道11的外管115近端上,第一连接器16用于向第一流体通道111提供第一流体。流通管道11的内管114的近端与第二连接器17的远端固定连接,第二连接器17用于向第二流体通道113提供第二流体。Optionally, the distal peripheral wall of the head end 15 is provided with an injection port 151 communicating with the hollow cavity 150 of the head end 15 . The injection port 151 is used to inject the second fluid. The hollow cavity 150 and the injection port 151 can inject the second fluid at the same time, so as to increase the injection area of the second fluid, thereby improving the ablation efficiency. The number of injection ports 151 may be one or more. When the number of injection ports 151 is more than one, the one or more injection ports 151 are provided along the circumferential direction of the head end 15 . Optionally, a step 153 is formed on the inner wall of the hollow cavity 150 . The distal end of the inner tube 114 is received in the hollow cavity 150 and abuts against the step 153 . The step 153 is used to limit the head end 15 when mating with the inner tube 114 , so as to increase the connection stability between the head end 15 and the inner tube 114 . Please refer to FIG. 1 and FIG. 2 again, the first conduit 10 further includes a first connector 16 and a second connector 17 . The first connector 16 is fixedly sleeved on the proximal end of the outer tube 115 of the flow channel 11 , and the first connector 16 is used for providing the first fluid to the first fluid channel 111 . The proximal end of the inner tube 114 of the flow channel 11 is fixedly connected to the distal end of the second connector 17 , and the second connector 17 is used to provide the second fluid to the second fluid channel 113 .
更为具体的,第一连接器16包括固定连接的第一管体161与第一注入管163。第一管体161与第一注入管163连接呈Y形结构。第一注入管163具有第一流体注入口1631。流通管道11的外管115与内管114均穿设于第一管体161。内管114露出第一管体161的近端。第一注入管163与第一流体通道111连通。第一流体注入口1631用于向第一管体161注入第一流体,并经第一注入管163流入第一流体通道111,以使可膨胀构件13膨胀。第一管体161的近端可与穿过第一管体161的内管114通过胶水或注塑等方式固定连接,以减少第一管体161与内管114之间相对运动的可能性。More specifically, the first connector 16 includes a first tube body 161 and a first injection tube 163 that are fixedly connected. The first pipe body 161 is connected with the first injection pipe 163 to form a Y-shaped structure. The first injection pipe 163 has a first fluid injection port 1631 . Both the outer tube 115 and the inner tube 114 of the circulation channel 11 pass through the first tube body 161 . The inner tube 114 exposes the proximal end of the first tube body 161 . The first injection pipe 163 communicates with the first fluid passage 111 . The first fluid injection port 1631 is used for injecting the first fluid into the first tube body 161 and flowing into the first fluid channel 111 through the first injection tube 163 to inflate the expandable member 13 . The proximal end of the first tube body 161 can be fixedly connected with the inner tube 114 passing through the first tube body 161 through glue or injection molding to reduce the possibility of relative movement between the first tube body 161 and the inner tube 114 .
本实施方式中,第二连接器17的远端与第一连接器16的近端之间的轴向距离范围包括但不限定为100mm-200mm。In this embodiment, the axial distance between the distal end of the second connector 17 and the proximal end of the first connector 16 includes but is not limited to 100mm-200mm.
第二连接器17包括固定连接的第二管体171与第二注入管173。第二管体171与第二注 入管173连接呈Y形结构。第二注入管173具有第二流体注入口1731。第二管体171的远端与流通管道11的内管114的近端固定连接。第二管体171与第二流体通道113连通。第二流体注入口1731用于向第二管体171注入第一流体,并经第二注入管173流入第二流体通道113。第二管体171的近端可与穿过第二管体171的内管114通过胶水或注塑等方式固定连接,以减少第二管体171与内管114之间相对运动的可能性。The second connector 17 includes a second tube body 171 and a second injection tube 173 that are fixedly connected. The second pipe body 171 is connected with the second injection pipe 173 to form a Y-shaped structure. The second injection pipe 173 has a second fluid injection port 1731 . The distal end of the second tube body 171 is fixedly connected with the proximal end of the inner tube 114 of the flow channel 11 . The second tube body 171 communicates with the second fluid channel 113 . The second fluid injection port 1731 is used for injecting the first fluid into the second tube body 171 and flowing into the second fluid channel 113 through the second injection tube 173 . The proximal end of the second tube body 171 can be fixedly connected with the inner tube 114 passing through the second tube body 171 through glue or injection molding to reduce the possibility of relative movement between the second tube body 171 and the inner tube 114 .
请结合参阅图1与图8,第二管体171包括沿第二管体171的轴向设置的第一插入孔1711,第二管体171的近端面设有与第一插入孔1711连通的扩口1713。第一导管10还包括密封垫18。密封垫18收容于扩口1713内并与第二管体171密封连接,用于防止血液及第二流体等溢出。密封垫18的外径可以略大于扩口1713的口径。密封垫18的材质包括但不限定为硅胶。密封垫18设有第二插入孔181。第二导管30穿设于第一插入孔1711及第二插入孔181。Please refer to FIG. 1 and FIG. 8 , the second tube body 171 includes a first insertion hole 1711 arranged along the axial direction of the second tube body 171 , and the proximal end surface of the second tube body 171 is provided to communicate with the first insertion hole 1711 Flaring 1713. The first conduit 10 also includes a gasket 18 . The gasket 18 is accommodated in the flaring opening 1713 and sealed with the second tube body 171 to prevent blood and the second fluid from overflowing. The outer diameter of the gasket 18 may be slightly larger than the diameter of the flaring 1713 . The material of the gasket 18 includes but is not limited to silica gel. The gasket 18 is provided with a second insertion hole 181 . The second conduit 30 passes through the first insertion hole 1711 and the second insertion hole 181 .
可选地,第一导管10还包括与第二管体171的近端固定连接的尾盖19。本实施方式中,第二管体171的外壁上设有外螺纹1715,尾盖19设有与外螺纹1715适配的内螺纹(图未示),第二管体171与尾盖19螺接。可以理解,本申请不限定第二管体171与尾盖19的连接方式。密封垫18固定收容于尾盖19内。尾盖19的近端设有导管孔191。第二导管30穿设于导管孔191。Optionally, the first catheter 10 further includes a tail cap 19 fixedly connected to the proximal end of the second tube body 171 . In this embodiment, the outer wall of the second pipe body 171 is provided with an external thread 1715, and the tail cap 19 is provided with an internal thread (not shown) adapted to the external thread 1715, and the second pipe body 171 is screwed to the tail cap 19. . It can be understood that the present application does not limit the connection method between the second pipe body 171 and the tail cap 19 . The gasket 18 is fixedly accommodated in the tail cap 19 . The proximal end of the tail cap 19 is provided with a conduit hole 191 . The second conduit 30 passes through the conduit hole 191 .
请参阅图9,第二导管30包括金属轴管31、柔性管32、电极33、支撑丝34及电连接器35。Please refer to FIG. 9 , the second catheter 30 includes a metal shaft tube 31 , a flexible tube 32 , an electrode 33 , a support wire 34 and an electrical connector 35 .
金属轴管31的远端与柔性管32的近端固定连接。金属轴管31的近端与电连接器35固定连接。The distal end of the metal shaft tube 31 is fixedly connected with the proximal end of the flexible tube 32 . The proximal end of the metal shaft tube 31 is fixedly connected with the electrical connector 35 .
柔性管32的远端露出流通管道11的内管114远端。本实施方式中,柔性管32的材质包括但不限定为树脂材料,例如,树脂材料包括热塑性聚氨酯弹性体橡胶(thermoplastic polyurethanes,TPU)或pebax。柔性管32的近端设有扩口结构(图未示),以方便插入金属轴管31,进而方便柔性管32的近端与金属轴管31之间的组装。本实施方式中,金属轴管31的远端插入至柔性管32的近端扩口结构并用胶水等方式进行粘接,金属轴管31的近端通过胶水粘接等方式与电连接器35相连。金属轴管31的材质不作具体限定,可以为不锈钢、镍钛合金等金属材质。柔性管32的内径尺寸范围可以为0.25mm-1.2mm,例如,柔性管32的内径可以为0.35mm。可以理解,金属轴管31与柔性管32之间的连接方式不限定为粘接,例如,还可以为卡接等。The distal end of the flexible tube 32 emerges from the distal end of the inner tube 114 of the flow conduit 11 . In this embodiment, the material of the flexible tube 32 includes but is not limited to a resin material, for example, the resin material includes thermoplastic polyurethane elastomer rubber (thermoplastic polyurethanes, TPU) or pebax. The proximal end of the flexible tube 32 is provided with a flaring structure (not shown in the figure) to facilitate the insertion of the metal shaft tube 31 , thereby facilitating the assembly between the proximal end of the flexible tube 32 and the metal shaft tube 31 . In this embodiment, the distal end of the metal shaft tube 31 is inserted into the proximal flaring structure of the flexible tube 32 and bonded with glue, and the proximal end of the metal shaft tube 31 is connected to the electrical connector 35 through glue bonding. . The material of the metal shaft tube 31 is not specifically limited, and may be metal materials such as stainless steel and nickel-titanium alloy. The inner diameter of the flexible tube 32 may range from 0.25 mm to 1.2 mm, for example, the inner diameter of the flexible tube 32 may be 0.35 mm. It can be understood that the connection method between the metal shaft tube 31 and the flexible tube 32 is not limited to bonding, for example, it may also be snap-fitting or the like.
柔性管32包括承载部321及连接部323。连接部323的远端与承载部321的近端固定连接。扩口结构设于连接部323的近端。扩口结构的内径略大于金属轴管31远端的外径。连接部323穿设于流通管道11的内管114。承载部321位于流通管道11外,电极33设于承载部321上。The flexible tube 32 includes a bearing portion 321 and a connecting portion 323 . The distal end of the connecting portion 323 is fixedly connected to the proximal end of the carrying portion 321 . The flaring structure is disposed at a proximal end of the connecting portion 323 . The inner diameter of the flaring structure is slightly larger than the outer diameter of the distal end of the metal shaft tube 31 . The connecting portion 323 is passed through the inner tube 114 of the flow channel 11 . The carrying portion 321 is located outside the flow channel 11 , and the electrodes 33 are disposed on the carrying portion 321 .
电极33设于柔性管32的远端并与电连接器35电连接以用于进行电位标测。电极33包括环电极331及头电极333。环电极331及头电极333均用于进行电位标测。环电极331套设于柔性管32的承载部321上并与电连接器35通过导线37电连接。本实施方式中,环电极331的数量为多个,多个环电极331沿柔性管32的轴向排列设置。每个环电极331与电连接器35通过一根导线37连接,以能够分别控制施加在环电极331上的电压。导线37包括但不限定为漆包铜线。头电极333固定于柔性管32的最远端,头电极333与电连接器35通过导线37电连接。导线37与环电极331、头电极333的连接方式为焊接或其它连接方式。The electrode 33 is disposed at the distal end of the flexible tube 32 and is electrically connected to the electrical connector 35 for potential mapping. The electrodes 33 include ring electrodes 331 and head electrodes 333 . Both the ring electrode 331 and the head electrode 333 are used for potential mapping. The ring electrode 331 is sheathed on the bearing portion 321 of the flexible tube 32 and is electrically connected to the electrical connector 35 through the wire 37 . In this embodiment, there are multiple ring electrodes 331 , and the multiple ring electrodes 331 are arranged along the axial direction of the flexible tube 32 . Each ring electrode 331 is connected to the electrical connector 35 through a wire 37 so as to be able to control the voltage applied to the ring electrodes 331 respectively. The wire 37 includes, but is not limited to, an enameled copper wire. The head electrode 333 is fixed on the farthest end of the flexible tube 32 , and the head electrode 333 is electrically connected to the electrical connector 35 through a wire 37 . The wire 37 is connected to the ring electrode 331 and the head electrode 333 by welding or other connection methods.
可以理解,在其他实施方式中,电极33可以省略头电极333,通过环电极331进行电位标测。It can be understood that, in other implementation manners, the electrode 33 may omit the head electrode 333 and perform potential mapping through the ring electrode 331 .
需要说明的是,在一种可能的实现方式中,电极33还可以配置为产生脉冲电场,用于对目标组织区域进行脉冲消融。脉冲消融利用高强度的脉冲电场使细胞膜发生不可逆电击穿,在医学领域称之为不可逆电穿孔(Irreversible electroporation,IRE),使细胞凋亡从而实现非热效应消融细胞,所以不受热沉效应影响。高电压脉冲序列产热少,不需要生理盐水冲洗来冷却,可有效减少气爆、焦痂和血栓的发生。脉冲消融治疗时间短,施加一组脉冲序列的治疗时间不到1分钟,全程消融时间一般不超过5分钟。且由于不同组织对脉冲电场的反应阈值存在差异,为消融心肌而不干扰其他临近组织提供了可能,从而可避免误伤临近的组织。另外,相较于其他能量,脉冲消融不需要热传导来对深层组织消融,所有分布在一定电场强度之上的心肌细胞均会发生电穿孔,降低了消融时对导管贴靠压力的要求。因此即使消融器械没有完全地贴合组织内壁,也不影响IRE消融效果。It should be noted that, in a possible implementation manner, the electrode 33 may also be configured to generate a pulse electric field for pulse ablation of the target tissue region. Pulse ablation uses a high-intensity pulsed electric field to cause irreversible electrical breakdown of the cell membrane, which is called irreversible electroporation (IRE) in the medical field, to cause cell apoptosis to achieve non-thermal ablation of cells, so it is not affected by the heat sink effect. The high-voltage pulse sequence produces less heat and does not need saline irrigation for cooling, which can effectively reduce the occurrence of gas explosion, eschar and thrombus. The pulse ablation treatment time is short, the treatment time of applying a set of pulse sequences is less than 1 minute, and the whole ablation time is generally no more than 5 minutes. And because different tissues have different response thresholds to pulsed electric fields, it is possible to ablate the myocardium without disturbing other adjacent tissues, thereby avoiding accidental injury to adjacent tissues. In addition, compared with other energies, pulse ablation does not require heat conduction to ablate deep tissues, and all cardiomyocytes distributed above a certain electric field strength will undergo electroporation, which reduces the pressure requirements for catheter abutment during ablation. Therefore, even if the ablation device does not completely adhere to the inner wall of the tissue, the ablation effect of IRE will not be affected.
虽然高压脉冲可以选择为通过电极33传递的能量形式,其它形式的能量可以额外地或替代地发出,例如射频能量或者其他任何合适形式的能量。也即,电极33还可以配置为传递射频能量或者其他合适形式的能量(例如微波)对目标组织区域进行消融治疗。While high voltage pulses may be selected as the form of energy delivered through electrodes 33, other forms of energy may additionally or alternatively be delivered, such as radio frequency energy or any other suitable form of energy. That is, the electrodes 33 may also be configured to transmit radiofrequency energy or other suitable forms of energy (eg, microwaves) to perform ablation treatment on the target tissue region.
支撑丝34穿设于柔性管32,用于支撑柔性管32。支撑丝34包括位于支撑丝34远端的小径部(图未示)和位于支撑丝34近端的大径部(图未示)。大径部的外径大于小径部的外径,小径部穿设于柔性管32的承载部321与连接部323。支撑丝34包括但不限于镍钛合金材质。支撑丝34具有超弹性和记忆特性,起到支撑作用,用以保证第二导管30的远端具有一定的刚性。由于支撑丝34的远端细近端粗,使得第二导管30的远端具有刚性的同时亦具有较好的柔软性,进而减少手术时第二导管30对血管的损伤。支撑丝34的直径尺寸范围为0.10mm-0.40mm,例如支撑丝34的直径尺寸为0.18mm。The supporting wire 34 passes through the flexible tube 32 for supporting the flexible tube 32 . The support wire 34 includes a small diameter portion (not shown) located at the distal end of the support wire 34 and a large diameter portion (not shown) located at the proximal end of the support wire 34 . The outer diameter of the large-diameter portion is greater than that of the small-diameter portion, and the small-diameter portion passes through the bearing portion 321 and the connecting portion 323 of the flexible tube 32 . The support wire 34 includes but is not limited to nickel-titanium alloy. The support wire 34 has superelasticity and memory properties, and plays a supporting role to ensure the rigidity of the distal end of the second catheter 30 . Since the distal end of the support wire 34 is thinner and the proximal end is thicker, the distal end of the second catheter 30 has rigidity and flexibility at the same time, thereby reducing damage to blood vessels caused by the second catheter 30 during surgery. The diameter of the support wire 34 ranges from 0.10 mm to 0.40 mm, for example, the diameter of the support wire 34 is 0.18 mm.
电连接器35用于连接导线37与监测设备。本实施方式中,电连接器35的一端设置有用于连接焊接导线37的针脚,另一端设置有用于与监测设备快速连接的接口结构。The electrical connector 35 is used to connect the wire 37 with the monitoring equipment. In this embodiment, one end of the electrical connector 35 is provided with pins for connecting the welding wire 37 , and the other end is provided with an interface structure for quick connection with monitoring equipment.
在一些可能的实现方式中,如图10所示,承载部321包括螺旋结构3213,螺旋结构3213沿连接部323的轴向螺旋延伸,环电极331设于螺旋结构3213上,头电极333设于承载部321的最远端,螺旋状结构的径向尺寸与血管的直径相当,这样一来,以使承载部321上的环电极331与血管壁能够更好地贴靠,从而有利于提高心内电位测定的准确性。螺旋状结构的径向尺寸是指螺旋状结构垂直轴向方向上的尺寸。In some possible implementations, as shown in FIG. 10 , the bearing part 321 includes a helical structure 3213, the helical structure 3213 extends helically along the axial direction of the connecting part 323, the ring electrode 331 is arranged on the helical structure 3213, and the head electrode 333 is arranged on the At the farthest end of the bearing part 321, the radial dimension of the helical structure is equivalent to the diameter of the blood vessel. In this way, the ring electrode 331 on the bearing part 321 can be better attached to the blood vessel wall, which is beneficial to improve the heart rate. The accuracy of the internal potential measurement. The radial dimension of the helical structure refers to the dimension in the direction perpendicular to the axial direction of the helical structure.
由于Marshall静脉为冠状静脉窦的一分支血管,传统的直导管较难准确进入。在一些可能的实现方式中,如图11所示,承载部321包括弯形结构3215,弯形结构3215设置于承载部321的最远端并相对连接部323的轴向弯曲设置。弯形结构3215相对于连接部323的轴向或第一导管的轴向弯曲角度范围为不小于90°且不大于150°,即弯形结构3215相对于连接部323的轴线的弯曲角度范围为[90°,150°]。Marshall静脉与冠状静脉窦的夹角约为90°至150°。由于弯形结构3215相对于连接部323的轴线的弯曲角度,与Marshall静脉与冠状静脉窦的夹角大致相同,这样一来,第二导管30既可以很好地进入其血管,也不会大幅增加制造成本。Since the vein of Marshall is a branch of the coronary sinus, it is difficult to accurately enter the traditional straight catheter. In some possible implementations, as shown in FIG. 11 , the carrying portion 321 includes a curved structure 3215 , and the curved structure 3215 is disposed at the farthest end of the carrying portion 321 and is bent relative to the axial direction of the connecting portion 323 . The bending angle range of the curved structure 3215 relative to the axial direction of the connecting portion 323 or the axial direction of the first conduit is not less than 90° and not greater than 150°, that is, the bending angle range of the curved structure 3215 relative to the axis of the connecting portion 323 is [90°,150°]. The angle between the vein of Marshall and the coronary sinus is approximately 90° to 150°. Since the bending angle of the curved structure 3215 relative to the axis of the connecting portion 323 is approximately the same as the angle between the vein of Marshall and the coronary sinus, in this way, the second catheter 30 can enter the blood vessel well without greatly Increase manufacturing cost.
在一些可能的实现方式中,如图12所示,承载部321包括螺旋结构3213与弯形结构3215,螺旋结构3213沿连接部323的轴向螺旋延伸,环电极331设于螺旋结构3213上,头电极333设于承载部321的最远端,弯形结构3215设置于承载部321的最远端并相对连接部323的轴向弯曲设置。承载部321结合了螺旋结构3213与弯形结构3215,其中,螺旋结构3213能够使承载部321上的环电极331与血管壁能够更好地贴靠,从而有利于提高心内电位测定的准确性。弯形结构3215相对于连接部323的轴向或第一导管的轴向弯曲角度范围为不小于90° 且不大于150°,即弯形结构3215相对于连接部323的轴线的弯曲角度范围为[90°,150°]。Marshall静脉与冠状静脉窦的夹角约为90°至150°。由于弯形结构3215相对于连接部323的轴线的弯曲角度,与Marshall静脉与冠状静脉窦的夹角大致相同,这样一来,第二导管30既可以很好地进入其血管,也不会大幅增加制造成本。In some possible implementations, as shown in FIG. 12 , the bearing part 321 includes a helical structure 3213 and a curved structure 3215, the helical structure 3213 extends helically along the axial direction of the connecting part 323, and the ring electrode 331 is disposed on the helical structure 3213. The head electrode 333 is disposed at the farthest end of the bearing portion 321 , and the curved structure 3215 is disposed at the farthest end of the bearing portion 321 and bent relative to the axial direction of the connecting portion 323 . The bearing part 321 combines the helical structure 3213 and the curved structure 3215, wherein the helical structure 3213 can make the ring electrode 331 on the bearing part 321 and the blood vessel wall can be better attached to, thereby helping to improve the accuracy of intracardiac potential measurement . The bending angle range of the curved structure 3215 relative to the axial direction of the connecting portion 323 or the axial direction of the first conduit is not less than 90° and not greater than 150°, that is, the bending angle range of the curved structure 3215 relative to the axis of the connecting portion 323 is [90°,150°]. The angle between the vein of Marshall and the coronary sinus is approximately 90° to 150°. Since the bending angle of the curved structure 3215 relative to the axis of the connecting portion 323 is approximately the same as the angle between the vein of Marshall and the coronary sinus, in this way, the second catheter 30 can enter the blood vessel well without greatly Increase manufacturing cost.
以目标组织区域为人体心脏为例,对第一实施方式提供的消融系统100A对人体心脏进行手术的操作步骤进行简单说明。其中,第一流体包括气体或液体,第二流体为无水乙醇。可以理解,本申请不限定目标组织区域为人体心脏,例如,肺部、肾部或者生物体的其他目标组织区域。Taking the target tissue region as the human heart as an example, the operation steps of the ablation system 100A provided in the first embodiment for operating the human heart will be briefly described. Wherein, the first fluid includes gas or liquid, and the second fluid is absolute ethanol. It can be understood that the present application does not limit the target tissue area to the human heart, for example, the lungs, kidneys or other target tissue areas of the living body.
(1)鞘管的插入(1) Insertion of the sheath
局部麻醉下通过右侧股静脉或者锁骨下静脉穿刺,经下腔静脉或者上腔静脉将鞘管送入右心房的冠状窦口部。Under local anesthesia, the right femoral vein or subclavian vein is punctured, and the sheath is sent to the coronary sinus ostium of the right atrium through the inferior vena cava or superior vena cava.
(2)指引导管的插入(2) Guide catheter insertion
通过造影导管确认存在Marshall静脉后,将指引导管插入鞘管的管腔,并使得指引导管位于Marshall静脉开口部。After confirming the existence of Marshall's vein through the contrast catheter, insert the guide catheter into the lumen of the sheath, and make the guide catheter located at the opening of Marshall's vein.
(3)第二导管30的插入(3) Insertion of the second catheter 30
将可以代替导丝使用的第二导管30沿着指引导管的管腔送至Marshall静脉远端,并进行电位测定。Send the second catheter 30 , which can be used instead of the guide wire, to the distal end of the Marshall vein along the lumen of the guiding catheter, and perform potential measurement.
(4)第一导管10的插入(4) Insertion of the first catheter 10
将第一导管10沿第二导管30送至Marshall静脉远端,后调整可膨胀构件13的位置使得第二可膨胀件133置于Marshall静脉近端,第一可膨胀件131置于Marshall静脉中远端。Send the first catheter 10 along the second catheter 30 to the distal end of the vein of Marshall, and then adjust the position of the expandable member 13 so that the second expandable member 133 is placed at the proximal end of the vein of Marshall, and the first expandable member 131 is placed in the vein of Marshall remote.
(5)可膨胀构件13扩张与乙醇注射消融(5) Expandable member 13 expansion and ethanol injection ablation
从第一连接器16的第一流体注入口1631注射第一流体至可膨胀构件13中,使得可膨胀构件13扩张,可膨胀构件13扩张之后,从第二连接器17的第二流体注入口1731缓慢推注第二流体(乙醇4-6ml,通常1ml/1min),第二流体沿着第一导管10的第二流体通道113喷射而出;观察2min后推注第二次。总计推注2-3次,第二流体的推注量总计不超过12ml。Inject the first fluid from the first fluid injection port 1631 of the first connector 16 into the expandable member 13, so that the expandable member 13 expands. 1731 Slowly inject the second fluid (4-6ml of ethanol, usually 1ml/1min), and the second fluid is sprayed out along the second fluid channel 113 of the first catheter 10; after 2 minutes of observation, inject the second fluid. A total of 2-3 bolus injections are performed, and the total bolus injection volume of the second fluid does not exceed 12ml.
(6)电位测定(6) Potential measurement
在第一导管10保持在Marshall静脉近端的状态下,用第二导管30对Marshall静脉进行电位测定。根据测定结果判定消融效果,消融不成功时无需将第二导管30撤出,可直接用第一导管10进行再次消融。消融结束后将第二导管30回撤至第一导管10,后将第一导管10及第二导管30共同回撤至指引导管及鞘管完成收鞘。With the first catheter 10 held proximal to the vein of Marshall, the second catheter 30 is used to perform potential measurements on the vein of Marshall. The ablation effect is judged according to the measurement results. When the ablation is unsuccessful, there is no need to withdraw the second catheter 30 , and the first catheter 10 can be directly used for re-ablation. After the ablation is completed, the second catheter 30 is retracted to the first catheter 10, and then the first catheter 10 and the second catheter 30 are retracted together to guide the catheter and the sheath to complete sheath retraction.
本实施方式提供的消融系统100A,可以在消融的同时进行电位的测定,实时监测心内电位并判断其消融效果,简化了消融手术步骤,缩短了手术时间,提高了消融效率。The ablation system 100A provided in this embodiment can measure the potential during ablation, monitor the intracardiac potential in real time and judge its ablation effect, which simplifies the ablation procedure, shortens the operation time, and improves the ablation efficiency.
请参阅图13与图14,本申请第二实施方式提供的一种消融系统100B与第一实施方式提供的消融系统100A的结构大致相同,不同在于,连接管135位于流通管道11的外部。Please refer to FIG. 13 and FIG. 14 , an ablation system 100B provided in the second embodiment of the present application has substantially the same structure as the ablation system 100A provided in the first embodiment, except that the connecting tube 135 is located outside the flow channel 11 .
较为具体的,请结合图15,流通管道11的远端包括沿流通管道11的轴向设置的第一区域116、第二区域117及第三区域118,第二区域117位于第一区域116与第三区域118之间。第一可膨胀件131位于第一区域116,第二可膨胀件133位于第三区域118。请结合图16,第二区域117包括第一设置区域1171及第二设置区域1173。第一设置区域1171用于设置连接管135。本实施方式中,流通管道11包括内管114与套设于内管114外的外管115。内管114的远端露出外管115的远端。More specifically, referring to FIG. 15 , the distal end of the flow channel 11 includes a first area 116 , a second area 117 and a third area 118 arranged along the axial direction of the flow channel 11 , and the second area 117 is located between the first area 116 and the third area 118 . Between the third area 118 . The first expandable element 131 is located in the first area 116 , and the second expandable element 133 is located in the third area 118 . Please refer to FIG. 16 , the second area 117 includes a first setting area 1171 and a second setting area 1173 . The first setting area 1171 is used for setting the connecting pipe 135 . In this embodiment, the circulation channel 11 includes an inner tube 114 and an outer tube 115 sleeved outside the inner tube 114 . The distal end of the inner tube 114 emerges from the distal end of the outer tube 115 .
连接管135具有管腔1350。连接管135的数量为多个,多个连接管135位于第二区域117的第一设置区域1171。多个连接管135沿露出外管115远端的内管114的周向间隔设置。沿流通管道11的周向,相邻的两个连接管135之间对应第二设置区域1173形成有间隙1353。内管114位于连接管135的管腔1350外部。内管114穿设于第一可膨胀件131的第一囊腔与第二可膨胀件131的第二囊腔。The connection tube 135 has a lumen 1350 . There are multiple connecting pipes 135 , and the multiple connecting pipes 135 are located in the first setting area 1171 of the second area 117 . A plurality of connecting tubes 135 are arranged at intervals along the circumference of the inner tube 114 exposing the distal end of the outer tube 115 . Along the circumferential direction of the flow pipe 11 , a gap 1353 is formed between two adjacent connecting pipes 135 corresponding to the second installation area 1173 . The inner tube 114 is located outside the lumen 1350 of the connecting tube 135 . The inner tube 114 passes through the first cavity of the first expandable component 131 and the second cavity of the second expandable component 131 .
内管114的侧壁设有用于喷射第二流体的喷射通孔119。喷射通孔119位于第二设置区域1173。喷射通孔119对应间隙1353的位置设置。The sidewall of the inner tube 114 is provided with an injection through hole 119 for injecting the second fluid. The injection through hole 119 is located in the second setting area 1173 . The spraying holes 119 are arranged corresponding to the positions of the gaps 1353 .
本申请对连接管135的截面形状不作限定,例如,连接管135的截面可以为图17所示的圆形,也可以是扇形等。又如,在一些实施方式中,请参阅图17,连接管135的截面大致呈扁平状,连接管135包括第一侧壁1355、第二侧壁1356、第三侧壁1357及第四侧壁1358。第一侧壁1355与第三侧壁1357相对设置,第一侧壁1335与第三侧壁1357均为弧形壁。第一侧壁1355与内管114的外壁相吻合,以使第一侧壁1355能够与内管114的外壁能够很好地贴合在一起。可以理解,在一些实施方式中,连接管135至少部分外壁与内管114的外壁相吻合,以使连接管135与内管114能够更好地贴靠于一起。The application does not limit the cross-sectional shape of the connecting pipe 135 , for example, the cross-section of the connecting pipe 135 may be circular as shown in FIG. 17 , or may be fan-shaped. As another example, in some embodiments, referring to FIG. 17 , the cross section of the connecting pipe 135 is substantially flat, and the connecting pipe 135 includes a first side wall 1355 , a second side wall 1356 , a third side wall 1357 and a fourth side wall. 1358. The first side wall 1355 is opposite to the third side wall 1357 , and both the first side wall 1335 and the third side wall 1357 are arc-shaped walls. The first side wall 1355 coincides with the outer wall of the inner tube 114 , so that the first side wall 1355 and the outer wall of the inner tube 114 can fit together well. It can be understood that, in some embodiments, at least part of the outer wall of the connecting tube 135 coincides with the outer wall of the inner tube 114 , so that the connecting tube 135 and the inner tube 114 can be better attached together.
可以理解,本申请不限定流通管道11的结构,例如,流通管道11可以为多腔管道,流通管道11具有第一流体通道与第二流体通道即可,在其他实施方式中,连接管135的数量可以为至少一个,连接管135至少位于第二区域117且流通管道11位于所有连接管135的管腔1350外部,流通管道11穿设于第一可膨胀件131的第一囊腔与第二可膨胀件133的第二囊腔。It can be understood that the present application does not limit the structure of the flow pipe 11. For example, the flow pipe 11 can be a multi-lumen pipe, and the flow pipe 11 only needs to have a first fluid channel and a second fluid channel. In other embodiments, the connecting pipe 135 The number can be at least one, the connecting tube 135 is at least located in the second region 117 and the flow channel 11 is located outside the lumen 1350 of all the connecting tubes 135, and the flow channel 11 is passed through the first cavity and the second cavity of the first expandable member 131. The second bladder of the expandable member 133 .
可以理解,在其他实施方式中,连接管135的数量为至少两个时,至少两个连接管135沿流通管道11的周向间隔设置,沿流通管道11的周向,相邻的两个连接管135之间形成有间隙1353,流通管道11对应间隙1353的位置设有喷射通孔119。优选地,喷射通孔119的数量与连接管135的数量相同。在流通管道11为多腔管道时,流通管道11的第二流体通道113的侧壁设有喷射通孔119。It can be understood that, in other embodiments, when the number of connecting pipes 135 is at least two, at least two connecting pipes 135 are arranged at intervals along the circumferential direction of the flow pipe 11, and along the circumferential direction of the flow pipe 11, adjacent two connecting pipes 135 are connected A gap 1353 is formed between the tubes 135 , and the position of the flow pipe 11 corresponding to the gap 1353 is provided with an injection through hole 119 . Preferably, the number of spray through holes 119 is the same as the number of connecting pipes 135 . When the flow pipe 11 is a multi-lumen pipe, the side wall of the second fluid channel 113 of the flow pipe 11 is provided with an injection through hole 119 .
第二实施方式提供的消融系统100B,第一可膨胀件131与第二可膨胀件133通过至少一个连接管135连接,使得流通管道11设有喷射通孔119的结构段无需与连接管135进行密封处理,如此,有利于简化消融系统100B的结构与制备。In the ablation system 100B provided in the second embodiment, the first expandable member 131 and the second expandable member 133 are connected through at least one connecting tube 135, so that the structural section of the flow channel 11 provided with the injection through hole 119 does not need to be connected with the connecting tube 135. The sealing process, in this way, facilitates the construction and manufacture of the ablation system 100B.
请参阅图18与图19,本申请第三实施方式提供的一种消融系统100C与第一实施方式提供的消融系统100A的结构大致相同,不同在于,第一导管10省略了连接管135。Please refer to FIG. 18 and FIG. 19 , an ablation system 100C provided in the third embodiment of the present application has substantially the same structure as the ablation system 100A provided in the first embodiment, except that the first catheter 10 omits the connecting tube 135 .
较为具体的,请结合参阅图20与图21,流通管道11的远端包括沿流通管道11的轴向设置的第一区域116、第二区域117及第三区域118。第二区域117位于第一区域116与第三区域118之间。第一可膨胀件131位于第一区域116,第二可膨胀件133位于第三区域118。第二区域117包括第一设置区域1171及第二设置区域1173。More specifically, please refer to FIG. 20 and FIG. 21 in conjunction. The distal end of the flow channel 11 includes a first area 116 , a second area 117 and a third area 118 arranged along the axial direction of the flow channel 11 . The second area 117 is located between the first area 116 and the third area 118 . The first expandable element 131 is located in the first area 116 , and the second expandable element 133 is located in the third area 118 . The second area 117 includes a first setting area 1171 and a second setting area 1173 .
可膨胀构件13还包括覆盖于第一设置区域1171的导气部137,用于连通第一可膨胀件131与第二膨胀件133。导气部137的远端固定连接于第一可膨胀件131的近端,导气部137的近端与第二可膨胀件133的远端固定连接。导气部137具有连通第一膨胀件131的第一囊腔与第二膨胀件133的第二囊腔的导气通道1371。第二设置区域1173裸露在导气部137的外部。内管114贯通第二流体通道113的侧壁在第二设置区域1173形成用于喷射第二流体的喷射通孔119。喷射通孔119与第一可膨胀件131的中心之间的间距,大致为第一可膨胀件131的中心与第二可膨胀件133的中心之间间距的二分之一。The expandable member 13 further includes an air guiding portion 137 covering the first setting area 1171 for communicating with the first expandable part 131 and the second expandable part 133 . The distal end of the air guide part 137 is fixedly connected to the proximal end of the first expandable part 131 , and the proximal end of the air guide part 137 is fixedly connected to the distal end of the second expandable part 133 . The air guide part 137 has an air guide channel 1371 communicating with the first cavity of the first expansion part 131 and the second cavity of the second expansion part 133 . The second installation area 1173 is exposed outside the air guiding part 137 . The inner tube 114 passes through the side wall of the second fluid passage 113 to form an injection hole 119 for injecting the second fluid in the second installation area 1173 . The distance between the injection through hole 119 and the center of the first expandable part 131 is roughly half of the distance between the center of the first expandable part 131 and the center of the second expandable part 133 .
本实施方式中,第一可膨胀件131与第二可膨胀件133为一体成型,由于无连接管,结构简单,制造工艺简单。In this embodiment, the first expandable part 131 and the second expandable part 133 are integrally formed, and since there is no connecting pipe, the structure is simple and the manufacturing process is simple.
可以理解,流通管道11的结构不作限定,例如,流通管道11为多腔管道时,流通管道11的第二流体通道113的侧壁在第二设置区域1173形成用于喷射第二流体的喷射通孔119。It can be understood that the structure of the flow pipe 11 is not limited. For example, when the flow pipe 11 is a multi-lumen pipe, the side wall of the second fluid channel 113 of the flow pipe 11 forms an injection channel for spraying the second fluid in the second setting area 1173. Hole 119.
请参阅图22与图23,本申请第四实施方式提供的一种消融系统100D与第一实施方式提供的消融系统100A的结构大致相同,不同在于,流通管道11为多腔管道。Please refer to FIG. 22 and FIG. 23 , an ablation system 100D provided by the fourth embodiment of the present application is substantially the same in structure as the ablation system 100A provided by the first embodiment, except that the flow channel 11 is a multi-lumen channel.
流通管道11包括第一流体通道111、第二流体通道113及收容腔121,第一流体通道111与第二流体通道113相互隔离设置,收容腔121与第一流体通道111相互隔离设置,收容腔121与第二流体通道113相互隔离设置,第二导管30穿设于收容腔121。The circulation channel 11 includes a first fluid channel 111, a second fluid channel 113 and a receiving chamber 121, the first fluid channel 111 and the second fluid channel 113 are isolated from each other, the receiving cavity 121 is isolated from the first fluid channel 111, and the receiving cavity 121 is isolated from the second fluid channel 113 , and the second conduit 30 passes through the receiving cavity 121 .
本实施方式中,流通管道11的截面形状大致为圆形,收容腔121的截面形状大致为圆形。收容腔121位于第一流体通道111与第二流体通道113之间,收容腔121的截面面积大于第一流体通道111的截面面积,收容腔121的截面面积大于第二流体通道113的截面面积,以使第二导管30在收容腔121的活动空间充足。In this embodiment, the cross-sectional shape of the circulation channel 11 is approximately circular, and the cross-sectional shape of the storage cavity 121 is approximately circular. The receiving cavity 121 is located between the first fluid channel 111 and the second fluid channel 113, the sectional area of the receiving cavity 121 is larger than the sectional area of the first fluid channel 111, the sectional area of the receiving cavity 121 is larger than the sectional area of the second fluid channel 113, So that the movement space of the second conduit 30 in the receiving cavity 121 is sufficient.
由于第二导管30穿设于独立的收容腔121内,第二导管30相对流通管道11运动时,不会受到第二流体的干扰,有利于提高第二导管30相对流通管道11运动的顺畅性。Since the second conduit 30 is installed in the independent accommodation cavity 121, when the second conduit 30 moves relative to the flow conduit 11, it will not be disturbed by the second fluid, which is beneficial to improve the smoothness of the movement of the second conduit 30 relative to the flow conduit 11 .
可以理解,本申请不限定流通管道11的截面形状,收容腔121的截面形状,第一流体通道111的截面形状,第二流体通道113的截面形状。It can be understood that the present application does not limit the cross-sectional shape of the circulation channel 11 , the cross-sectional shape of the receiving chamber 121 , the cross-sectional shape of the first fluid channel 111 , and the cross-sectional shape of the second fluid channel 113 .
请参阅图24与图25,本申请第五实施方式提供的一种消融系统100E与第一实施方式提供的消融系统100A的结构大致相同,可膨胀构件13还包括第三可膨胀件139,第三可膨胀件139具有第三囊腔1390,第三囊腔1390与第一囊腔1310、第二囊腔1330连通。Please refer to FIG. 24 and FIG. 25 , an ablation system 100E provided by the fifth embodiment of the present application is substantially the same in structure as the ablation system 100A provided by the first embodiment, and the expandable member 13 also includes a third expandable member 139 , the first The three expandable elements 139 have a third cavity 1390 , and the third cavity 1390 communicates with the first cavity 1310 and the second cavity 1330 .
在第五实施方式中,第一可膨胀件131的近端与第二可膨胀件133的远端通过一个连接管135连接并相通,第二可膨胀件133的近端与第三可膨胀件139的远端通过一个连接管135连接并相通,第三可膨胀件139的近端与外管115的远端固定连接。In the fifth embodiment, the proximal end of the first expandable element 131 and the distal end of the second expandable element 133 are connected and communicated through a connecting tube 135, and the proximal end of the second expandable element 133 is connected to the third expandable element. The distal end of the third expandable element 139 is connected and communicated with by a connecting tube 135 , and the proximal end of the third expandable element 139 is fixedly connected with the distal end of the outer tube 115 .
第一可膨胀件131的近端与第二可膨胀件133的远端之间的连接管135,第二可膨胀件133的远端与第三可膨胀件139的远端之间的连接管135上均设有破口1351,内管114贯通第二流体通道113的侧壁设有用于喷射第二流体的喷射通孔119,喷射通孔119的位置对应破口1351的位置。The connecting tube 135 between the proximal end of the first expandable part 131 and the distal end of the second expandable part 133, the connecting tube between the distal end of the second expandable part 133 and the distal end of the third expandable part 139 135 are provided with breaches 1351, the inner tube 114 runs through the side wall of the second fluid passage 113 and is provided with injection through holes 119 for injecting the second fluid, and the positions of the injection through holes 119 correspond to the positions of the breaches 1351.
连接管135的管腔的内壁包括第一密封区域,第一密封区域环绕破口1351的周沿设置。流通管道11环绕喷射通孔119设有第二密封区域。第一密封区域与第二密封区域密封连接,以确保破口1351的边缘与内管114之间密封连接。第一密封区域与第二密封区域可以通过热熔等方式进行密封连接,以使破口1351的边缘与内管114之间密封连接。The inner wall of the lumen of the connecting tube 135 includes a first sealing area, and the first sealing area is arranged around the periphery of the opening 1351 . The flow pipe 11 is provided with a second sealing area around the injection through hole 119 . The first sealing area is in sealing connection with the second sealing area, so as to ensure the sealing connection between the edge of the opening 1351 and the inner tube 114 . The first sealing area and the second sealing area may be sealed and connected by heat fusion or the like, so that the edge of the breach 1351 is sealed and connected with the inner tube 114 .
本申请第五实施方式提供的消融系统100E,具有三个可膨胀件,以适应有较长血管的生物体。例如,由于部分患者可能Marshall静脉较长,两个可膨胀件无法实现一次性封堵并消融,三个可膨胀件的长度较长可有效进行封堵。The ablation system 100E provided by the fifth embodiment of the present application has three expandable components to adapt to organisms with relatively long blood vessels. For example, because some patients may have longer veins of Marshall, two expandable components cannot achieve one-time occlusion and ablation, and three expandable components with longer lengths can effectively occlude.
可以理解,流通管道11的结构不作限定,例如,流通管道11为多腔管道时,多膨胀件式的可膨胀构件13同样可适用。It can be understood that the structure of the flow channel 11 is not limited. For example, when the flow channel 11 is a multi-lumen channel, the expandable member 13 of multi-expansion element type is also applicable.
可以理解,本申请对第三可膨胀件139的位置不作限定,例如,第三可膨胀件139可以连接于第一可膨胀件131与第二可膨胀件133之间。It can be understood that the present application does not limit the position of the third expandable part 139 , for example, the third expandable part 139 may be connected between the first expandable part 131 and the second expandable part 133 .
可以理解,在其他实施方式中,可膨胀构件13还可以包括第四膨胀件、第五膨胀件…… 等等。It can be understood that in other embodiments, the expandable member 13 may also include a fourth expansion member, a fifth expansion member, . . . and so on.
请参阅图26,本申请第六实施方式提供的一种消融系统100F与第一实施方式提供的消融系统100A的结构大致相同,不同至少在于,第一导管10的结构等。Please refer to FIG. 26 , an ablation system 100F provided in the sixth embodiment of the present application is substantially the same in structure as the ablation system 100A provided in the first embodiment, except that the structure of the first catheter 10 is different.
消融系统100F包括第一导管10与第二导管30。第一导管10用于对目标组织区域进行消融。第一导管10包括流通管道11和可膨胀构件13。请结合参阅图27,流通管道11包括相互隔离的第一流体通道111及第二流体通道113。可膨胀构件13套设于流通管道11上。第一流体通道111用于向可膨胀构件13提供第一流体以使可膨胀构件13膨胀,实现对血管进行封堵。第二流体通道113用于向目标组织区域提供用于消融的第二流体。第二导管30穿设于流通管道11,第二导管30从流通管道11的远端露出用于进行电位标测。The ablation system 100F includes a first catheter 10 and a second catheter 30 . The first catheter 10 is used to ablate a target tissue region. The first catheter 10 includes a flow conduit 11 and an expandable member 13 . Please refer to FIG. 27 , the flow channel 11 includes a first fluid channel 111 and a second fluid channel 113 which are isolated from each other. The expandable member 13 is sheathed on the flow channel 11 . The first fluid channel 111 is used to provide the first fluid to the expandable member 13 to expand the expandable member 13 to achieve occlusion of blood vessels. The second fluid channel 113 is used to provide a second fluid for ablation to the target tissue area. The second conduit 30 is passed through the flow conduit 11 , and the second conduit 30 is exposed from the distal end of the flow conduit 11 for potential mapping.
消融系统100F在通过第一导管10的第二流体通道113提供第二流体对目标组织区域进行消融时,第二导管30的远端可同时进行电位标测,一方面实现了在消融过程中对心内电位的实时监测,并能够根据实时监测到的心内电位判断消融效果,从而达到良好的治疗的目的,另一方面,本实施方式中的消融系统100F可在消融的同时进行心内电位测定,无需将消融和标测分开操作,因而大幅简化了手术步骤,缩短了手术时间。When the ablation system 100F provides the second fluid through the second fluid channel 113 of the first catheter 10 to ablate the target tissue area, the distal end of the second catheter 30 can simultaneously perform potential mapping. Real-time monitoring of intracardiac potential, and can judge the ablation effect according to the real-time monitored intracardiac potential, so as to achieve the purpose of good treatment. On the other hand, the ablation system 100F in this embodiment can perform intracardiac potential while ablation Measurement does not require separate operations for ablation and mapping, which greatly simplifies the operation steps and shortens the operation time.
流通管道11包括内管114与外管115。内管114穿设于外管115。内管114的外壁与外管113的内壁共同围成第一流体通道111。第一流体通道111的远端封闭。内管114设有第二流体通道113。第二导管30穿设于第二流体通道113。第二导管30的近端露出内管114的近端,第二导管30的远端露出内管114的远端。可膨胀构件13套设于内管114上,可膨胀构件13的近端与外管115的远端固定连接并与第一流体通道111连通。The flow channel 11 includes an inner tube 114 and an outer tube 115 . The inner tube 114 passes through the outer tube 115 . The outer wall of the inner tube 114 and the inner wall of the outer tube 113 jointly enclose the first fluid channel 111 . The distal end of the first fluid channel 111 is closed. The inner tube 114 is provided with a second fluid passage 113 . The second conduit 30 passes through the second fluid channel 113 . The proximal end of the second conduit 30 exposes the proximal end of the inner tube 114 , and the distal end of the second conduit 30 exposes the distal end of the inner tube 114 . The expandable member 13 is sheathed on the inner tube 114 , and the proximal end of the expandable member 13 is fixedly connected with the distal end of the outer tube 115 and communicated with the first fluid channel 111 .
内管114的具体结构、材质等,外管115的具体结构、材质等可以参考本申请第一实施方式。The specific structure, material, etc. of the inner tube 114 and the specific structure, material, etc. of the outer tube 115 can refer to the first embodiment of the present application.
可膨胀构件13包括沿流通管道11的轴向设置的第一可膨胀件131及第二可膨胀件133。第一可膨胀件131与第二可膨胀件133固定连接。第一可膨胀件131的具体结构与第二可膨胀件133的具体结构可以参考本申请第一实施方式。第一可膨胀件131具有第一囊腔1310,第二可膨胀件133具有第二囊腔1330。第一囊腔1310与第二囊腔1330连通,第二囊腔1330与第一流体通道111连通。换而言之,第一流体通道111用于向第一囊腔1310与第二囊腔1330输入第一流体。内管114的远端依次穿设于第二可膨胀件133的第二囊腔1330及第一可膨胀件131的第一囊腔1310。外管115的远端与第二可膨胀件133的近端固定连接。The expandable member 13 includes a first expandable part 131 and a second expandable part 133 disposed along the axial direction of the flow channel 11 . The first expandable part 131 is fixedly connected with the second expandable part 133 . For the specific structure of the first expandable member 131 and the specific structure of the second expandable member 133 , please refer to the first embodiment of the present application. The first expandable member 131 has a first bladder 1310 , and the second expandable member 133 has a second bladder 1330 . The first cavity 1310 communicates with the second cavity 1330 , and the second cavity 1330 communicates with the first fluid channel 111 . In other words, the first fluid channel 111 is used to input the first fluid into the first cavity 1310 and the second cavity 1330 . The distal end of the inner tube 114 passes through the second cavity 1330 of the second expandable element 133 and the first cavity 1310 of the first expandable element 131 in turn. The distal end of the outer tube 115 is fixedly connected to the proximal end of the second expandable member 133 .
第一可膨胀件131与第二可膨胀件133一体设置,第一导管10的第一可膨胀件131与第二可膨胀件133之间未设置连接管,以简化可膨胀构件13的结构,并方便了可膨胀构件13的制造。The first expandable part 131 and the second expandable part 133 are integrally arranged, and no connecting pipe is provided between the first expandable part 131 and the second expandable part 133 of the first catheter 10, so as to simplify the structure of the expandable member 13, And the manufacture of the expandable member 13 is facilitated.
请参阅图28,第一显影物141位于内管114对应第一可膨胀件131的位置,以在消融系统100F实现手术时标记第一可膨胀件131的位置。第二显影物143位于内管114对应第二可膨胀件133的位置,以在消融系统100F实现手术时标记第二可膨胀件133的位置。第一显影物141与第二显影物143均由不透X射线的材料制成。Referring to FIG. 28 , the first developing object 141 is located at the position of the inner tube 114 corresponding to the first expandable member 131 , so as to mark the position of the first expandable member 131 when the ablation system 100F performs an operation. The second developing object 143 is located at the position of the inner tube 114 corresponding to the second expandable member 133, so as to mark the position of the second expandable member 133 when the ablation system 100F performs an operation. Both the first developing object 141 and the second developing object 143 are made of X-ray opaque material.
头端15包括与第二流体通道113连通的中空腔150,用于喷射第二流体。头端15的远端周壁上未设置喷射口,以简化头端15的结构。The head end 15 includes a hollow cavity 150 communicating with the second fluid channel 113 for injecting the second fluid. The distal peripheral wall of the head end 15 is not provided with injection ports to simplify the structure of the head end 15 .
请参阅图26与图29,第一导管10还包括连接器58,连接器58套设于流通管道11的外管115与内管114,用于向第一流体通道111提供第一流体及向第二流体通道113提供第二流体。连接器58包括座体581、第一注入管583及第二注入管585。座体581套设于外管115上。座体581沿轴向设有相连通的第一安装孔5810与第二安装孔5811。第一安装孔5810贯 通座体581的远端端面。本实施方式中,第一安装孔5811的孔径大于第二安装孔5811的孔径。可以理解,第一安装孔5811的孔径与第二安装孔5811的孔径可以相同也可以不相同。座体581的外壁上设有第一点胶孔5813与第二点胶孔5814。相较于第一点胶孔5813,第二点胶孔5814更为靠近座体581的近端。第一点胶孔5813与第一安装孔5810相连通,第二点胶孔5814与第二安装孔5811相连通。Please refer to FIG. 26 and FIG. 29, the first conduit 10 further includes a connector 58, the connector 58 is sleeved on the outer tube 115 and the inner tube 114 of the flow channel 11, for providing the first fluid to the first fluid channel 111 and to the first fluid channel 111. The second fluid channel 113 provides a second fluid. The connector 58 includes a base body 581 , a first injection tube 583 and a second injection tube 585 . The seat body 581 is sheathed on the outer tube 115 . The seat body 581 defines a first installation hole 5810 and a second installation hole 5811 in communication with each other along the axial direction. The first installation hole 5810 runs through the distal end surface of the seat body 581. In this embodiment, the diameter of the first installation hole 5811 is larger than the diameter of the second installation hole 5811 . It can be understood that the diameter of the first installation hole 5811 and the diameter of the second installation hole 5811 may be the same or different. A first dispensing hole 5813 and a second dispensing hole 5814 are disposed on the outer wall of the base body 581 . Compared with the first glue dispensing hole 5813 , the second glue dispensing hole 5814 is closer to the proximal end of the seat body 581 . The first glue dispensing hole 5813 communicates with the first installation hole 5810 , and the second glue dispensing hole 5814 communicates with the second installation hole 5811 .
内管114与外管115均穿设于第一安装孔5810。内管114的近端露出外管115的近端并穿设于第二安装孔5811。本实施方式中,可以将胶体从第一点胶孔5813及第二点胶孔5814装入,使外管115的近端与座体581相固定,使内管114的近端与座体581相固定。可以理解,本申请对座体581与外管115之间的连接方式不作限定,本申请对座体581与内管114之间的连接方式不作限定。Both the inner tube 114 and the outer tube 115 pass through the first installation hole 5810 . The proximal end of the inner tube 114 exposes the proximal end of the outer tube 115 and passes through the second installation hole 5811 . In this embodiment, the colloid can be loaded from the first dispensing hole 5813 and the second dispensing hole 5814, so that the proximal end of the outer tube 115 is fixed to the seat body 581, and the proximal end of the inner tube 114 is connected to the seat body 581. phase fixed. It can be understood that the application does not limit the connection method between the seat body 581 and the outer tube 115 , and the application does not make limitations on the connection method between the seat body 581 and the inner tube 114 .
第一注入管583具有第一流体注入口5831,第一流体注入口5831用于向第一流体通道111注入第一流体。第二注入管585具有第二流体注入口5851,第二流体注入口5851用于向第二流体通道113注入第二流体。第一流体注入口5831与第二流体注入口5851设置在同一个座体581上,能够简化连接器58的结构,及方便消融系统100F的组装。The first injection pipe 583 has a first fluid injection port 5831 for injecting the first fluid into the first fluid channel 111 . The second injection pipe 585 has a second fluid injection port 5851 for injecting the second fluid into the second fluid channel 113 . The first fluid injection port 5831 and the second fluid injection port 5851 are disposed on the same seat body 581 , which can simplify the structure of the connector 58 and facilitate the assembly of the ablation system 100F.
座体581的近端面还设有与第二安装孔5811相连通的扩口5817。第一导管10还包括密封垫58。密封垫58收容于扩口5817内并与座体581密封连接,用于防止血液及第二流体等溢出。密封垫18的外径可以略大于扩口5817的口径。密封垫18上设有第二插入孔181。密封垫18的材质包括但不限定为硅胶。第二导管30穿设于第二安装孔5811及密封垫18的第二插入孔181。The proximal surface of the base body 581 is further provided with a flaring opening 5817 communicating with the second installation hole 5811 . The first conduit 10 also includes a gasket 58 . The sealing gasket 58 is accommodated in the flared opening 5817 and sealed with the seat body 581 to prevent blood and the second fluid from overflowing. The outer diameter of the gasket 18 can be slightly larger than the diameter of the flaring 5817. The gasket 18 is provided with a second insertion hole 181 . The material of the gasket 18 includes but is not limited to silica gel. The second conduit 30 passes through the second installation hole 5811 and the second insertion hole 181 of the gasket 18 .
可选地,第一导管10还包括与座体581的近端固定连接的尾盖62。尾盖62包括套设部621及收容于套设部621内的接合部623。接合部623的近端与套设部621的近端固定连接。套设部621的近端面上设有导管孔6210,导管孔6210贯通接合部623的近端面与接合部623的远端面。第二导管30穿设于导管孔6210。Optionally, the first catheter 10 further includes a tail cap 62 fixedly connected to the proximal end of the seat body 581 . The tail cover 62 includes a sleeve portion 621 and a joint portion 623 accommodated in the sleeve portion 621 . A proximal end of the engaging portion 623 is fixedly connected to a proximal end of the sleeve portion 621 . A catheter hole 6210 is formed on the proximal surface of the sheathing portion 621 , and the catheter hole 6210 passes through the proximal surface of the joint portion 623 and the distal surface of the joint portion 623 . The second conduit 30 passes through the conduit hole 6210 .
本实施方式中,座体581近端的外壁上设有外螺纹5819,套设部621的内壁上设有与外螺纹5819适配的内螺纹6213,座体581的外螺纹5819与尾盖62的内螺纹6213螺接。座体581的近端夹设于套设部621与接合部623之间,这样一来,座体581被限定在套设部621与接合部623之间而难以在径向方向上运动,从而能够提高消融系统100F的稳定性。In this embodiment, an external thread 5819 is provided on the outer wall of the proximal end of the seat body 581, and an internal thread 6213 matching the external thread 5819 is provided on the inner wall of the sleeve part 621. The internal thread 6213 is screwed. The proximal end of the base body 581 is sandwiched between the sleeve portion 621 and the joint portion 623, so that the base body 581 is limited between the sleeve portion 621 and the joint portion 623 and is difficult to move in the radial direction, thereby The stability of the ablation system 100F can be improved.
连接器58还包括套设于座体581的远端的护套60,流通管道11穿设于护套60。护套60用于保护流通管道11并提高流通管道11的强度,以降低流通管道11因弯折而受损的可能性。本实施方式中,内管114与外管115均穿设于护套60。The connector 58 further includes a sheath 60 sheathed on the distal end of the base body 581 , and the flow channel 11 is passed through the sheath 60 . The sheath 60 is used to protect the flow pipe 11 and improve the strength of the flow pipe 11 to reduce the possibility of the flow pipe 11 being damaged due to bending. In this embodiment, both the inner tube 114 and the outer tube 115 are passed through the sheath 60 .
本实施方式中,护套60的近端与座体581过盈配合,护套60的远端与流通管道11(例如外管115)间隙配合,护套60可以是硅胶、橡胶、TPU、Pebax等硬度相对较低的材质。本实施例优选橡胶。In this embodiment, the proximal end of the sheath 60 is in interference fit with the seat body 581, and the distal end of the sheath 60 is in clearance fit with the flow channel 11 (such as the outer tube 115). The sheath 60 can be made of silica gel, rubber, TPU, Pebax materials with relatively low hardness. Rubber is preferred for this embodiment.
可以理解,若消融系统100F中的连接器为分体设置,例如,本申请第一实施方式中的连接器包括第一连接器与第二连接器,第一连接器的远端可以套设有护套,及/或第二连接器的远端可以套设有护套。It can be understood that if the connectors in the ablation system 100F are split, for example, the connectors in the first embodiment of the present application include a first connector and a second connector, and the distal end of the first connector can be sleeved with The sheath, and/or the distal end of the second connector can be covered with a sheath.
可以理解,流通管道11的结构不作限定,例如,流通管道11为多腔管道时,一体式的连接器58同样可适用,流通管道11具有第一流体通道与第二流体通道即可。It can be understood that the structure of the flow pipe 11 is not limited. For example, when the flow pipe 11 is a multi-lumen pipe, the integrated connector 58 is also applicable, and the flow pipe 11 only needs to have a first fluid channel and a second fluid channel.
可以理解,在不同冲突的情况下,本申请第一实施方式至第六实施方式可以相互结合。It can be understood that, in the case of different conflicts, the first embodiment to the sixth embodiment of the present application can be combined with each other.
以上所揭露的仅为本申请较佳实施方式而已,当然不能以此来限定本申请之权利范围,因此依本申请权利要求所作的等同变化,仍属本申请所涵盖的范围。What is disclosed above is only a preferred implementation mode of the application, and of course it cannot limit the scope of rights of the application. Therefore, equivalent changes made according to the claims of the application still fall within the scope of the application.

Claims (31)

  1. 一种消融系统,其特征在于,包括第一导管与第二导管,所述第一导管包括流通管道和可膨胀构件,所述流通管道包括相互隔离的第一流体通道及第二流体通道;所述可膨胀构件套设于所述流通管道上,所述第一流体通道用于向所述可膨胀构件提供第一流体以使所述可膨胀构件膨胀;所述第二流体通道用于向目标组织区域提供用于消融的第二流体;所述第二导管穿设于所述流通管道,所述第二导管从所述流通管道的远端露出用于进行电位标测。An ablation system, characterized in that it includes a first catheter and a second catheter, the first catheter includes a flow channel and an expandable member, and the flow channel includes a first fluid channel and a second fluid channel that are isolated from each other; The expandable member is sleeved on the flow channel, the first fluid channel is used to provide the first fluid to the expandable member to expand the expandable member; the second fluid channel is used to supply the target The tissue area provides a second fluid for ablation; the second conduit is passed through the flow channel, and the second conduit is exposed from the distal end of the flow channel for potential mapping.
  2. 如权利要求1所述的消融系统,其特征在于,所述可膨胀构件包括沿所述流通管道轴向设置的第一可膨胀件及第二可膨胀件,所述第一可膨胀件与所述第二可膨胀件固定连接,所述第一可膨胀件具有第一囊腔,所述第二可膨胀件具有第二囊腔,所述第一囊腔与所述第二囊腔连通,所述第二囊腔与所述第一流体通道连通。The ablation system according to claim 1, wherein the expandable member comprises a first expandable part and a second expandable part arranged axially along the flow channel, the first expandable part and the The second expandable element is fixedly connected, the first expandable element has a first cavity, the second expandable element has a second cavity, and the first cavity communicates with the second cavity, The second pocket communicates with the first fluid channel.
  3. 如权利要求2所述的消融系统,其特征在于,所述第一可膨胀件与所述第二可膨胀件一体成型。The ablation system according to claim 2, wherein the first expandable element is integrally formed with the second expandable element.
  4. 如权利要求2所述的消融系统,其特征在于,所述可膨胀构件还包括位于所述流通管道外的连接管,所述连接管与所述第一可膨胀件固定连接,所述连接管与所述第二可膨胀件固定连接,所述连接管具有管腔,所述管腔连通所述第一囊腔与所述第二囊腔。The ablation system according to claim 2, wherein the expandable member further comprises a connecting tube located outside the flow channel, the connecting tube is fixedly connected to the first expandable element, and the connecting tube Fixedly connected with the second expandable element, the connecting tube has a lumen, and the lumen communicates with the first cavity and the second cavity.
  5. 如权利要求4所述的消融系统,其特征在于,所述流通管道穿设于所述管腔,所述连接管的近端与所述第二可膨胀件的远端固定连接,所述连接管的远端与所述第一可膨胀件的近端固定连接。The ablation system according to claim 4, characterized in that, the flow channel is passed through the lumen, the proximal end of the connecting tube is fixedly connected to the distal end of the second expandable member, and the connection The distal end of the tube is fixedly connected to the proximal end of the first expandable member.
  6. 如权利要求5所述的消融系统,其特征在于,所述连接管的管壁上设有破口,所述流通管道贯通所述第二流体通道的侧壁设有用于喷射所述第二流体的喷射通孔,所述喷射通孔的位置对应所述破口的位置,所述管腔的内壁包括第一密封区域,所述第一密封区域环绕所述破口的周沿设置,所述流通管道环绕所述喷射通孔设有第二密封区域,所述第一密封区域与所述第二密封区域密封连接。The ablation system according to claim 5, wherein a breach is provided on the tube wall of the connecting tube, and a wall for injecting the second fluid is provided on the side wall of the flow channel passing through the second fluid channel. The injection through hole, the position of the injection through hole corresponds to the position of the breach, the inner wall of the lumen includes a first sealing area, the first sealing area is arranged around the periphery of the breach, the The flow pipe is provided with a second sealing area around the injection through hole, and the first sealing area is in sealing connection with the second sealing area.
  7. 如权利要求4所述的消融系统,其特征在于,所述流通管道的远端包括沿所述流通管道的轴向设置的第一区域、第二区域及第三区域,所述第二区域位于所述第一区域与所述第三区域之间,所述第一可膨胀件位于所述第一区域,所述第二可膨胀件位于所述第三区域,所述连接管的数量为至少一个,所述连接管至少位于所述第二区域且所述流通管道位于所有连接管的管腔外部,所述流通管道穿设于所述第一囊腔与所述第二囊腔。The ablation system according to claim 4, wherein the distal end of the flow channel includes a first area, a second area and a third area arranged along the axial direction of the flow channel, and the second area is located at Between the first area and the third area, the first expandable element is located in the first area, the second expandable element is located in the third area, and the number of connecting pipes is at least One, the connecting tube is located at least in the second area and the flow channel is located outside the lumens of all the connecting tubes, and the flow channel passes through the first cavity and the second cavity.
  8. 如权利要求7所述的消融系统,其特征在于,所述流通管道贯通所述第二流体通道的侧壁设有用于喷射所述第二流体的喷射通孔,所述第二区域包括第一设置区域及第二设置区域,所述连接管位于所述第一设置区域,所述喷射通孔位于所述第二设置区域。The ablation system according to claim 7, characterized in that, the side wall of the flow channel passing through the second fluid channel is provided with an injection through hole for injecting the second fluid, and the second area includes a first A setting area and a second setting area, the connecting pipe is located in the first setting area, and the injection through hole is located in the second setting area.
  9. 如权利要求8所述的消融系统,其特征在于,所述连接管的数量为至少两个,所述至少两个连接管沿所述流通管道的周向间隔设置,沿所述流通管道的周向,相邻的两个所述连接管之间形成有间隙,所述流通管道对应所述间隙的位置设有所述喷射通孔。The ablation system according to claim 8, wherein the number of the connecting tubes is at least two, and the at least two connecting tubes are arranged at intervals along the circumference of the flow channel, and the number of the connecting tubes along the circumference of the flow channel In the direction, a gap is formed between two adjacent connecting pipes, and the spraying through hole is provided at a position corresponding to the gap in the flow pipe.
  10. 如权利要求2所述的消融系统,其特征在于,所述流通管道的远端包括沿所述流通管道的轴向设置的第一区域、第二区域及第三区域,所述第二区域位于所述第一区域与所述第三区域之间;所述第一可膨胀件位于所述第一区域,所述第二可膨胀件位于所述第三区域,所述第二区域包括第一设置区域及第二设置区域;所述可膨胀构件还包括覆盖于所述第一设置区域的导气部,所述导气部的远端与所述第一可膨胀件的近端固定连接,所述导气部的近端与所述第二可膨胀件的远端固定连接,所述导气部具有连通所述第一囊腔与所述第二囊腔的导气通道,所述第二设置区域裸露在所述导气部的外部,所述流通管道的第二流体通道的侧壁在所述第二设置区域形成用于喷射所述第二流体的喷射通孔。The ablation system according to claim 2, wherein the distal end of the flow channel comprises a first area, a second area and a third area arranged along the axial direction of the flow channel, and the second area is located at Between the first region and the third region; the first expandable member is located in the first region, the second expandable member is located in the third region, and the second region includes the first a setting area and a second setting area; the expandable member further includes an air guiding part covering the first setting area, the distal end of the air guiding part is fixedly connected to the proximal end of the first expandable part, The proximal end of the air guiding part is fixedly connected to the distal end of the second expandable part, the air guiding part has an air guiding channel communicating with the first cavity and the second cavity, and the first The second installation area is exposed outside the air guiding part, and the side wall of the second fluid channel of the flow duct forms an injection through hole for injecting the second fluid in the second installation area.
  11. 如权利要求2所述的消融系统,其特征在于,所述可膨胀构件还包括第三可膨胀件,所述第三可膨胀件具有第三囊腔,所述第三囊腔与所述第一囊腔、所述第二囊腔连通。The ablation system according to claim 2, wherein the expandable member further comprises a third expandable part, the third expandable part has a third cavity, and the third cavity is connected to the first The first cavity communicates with the second cavity.
  12. 如权利要求2所述的消融系统,其特征在于,所述消融系统还包括第一显影物与第二显影物,所述第一显影物位于所述第一可膨胀件上或位于所述流通管道上对应所述第一可膨胀件 的位置,所述第二显影物位于所述第二可膨胀件上或位于所述流通管道上对应所述第二可膨胀件的位置。The ablation system according to claim 2, wherein the ablation system further comprises a first developing object and a second developing object, the first developing object is located on the first expandable member or on the communication channel. The position on the pipeline corresponds to the first expandable component, and the second developer is located on the second expandable component or located on the flow channel at a position corresponding to the second expandable component.
  13. 如权利要求1-12任一项所述的消融系统,其特征在于,所述流通管道包括内管与外管,所述内管穿设于所述外管,所述内管设有所述第二流体通道;所述内管的外壁与所述外管的内壁共同围成所述第一流体通道;所述可膨胀构件套设于所述内管上,所述可膨胀构件的近端与所述外管的远端固定连接并与所述第一流体通道连通。The ablation system according to any one of claims 1-12, characterized in that, the flow channel comprises an inner tube and an outer tube, the inner tube is passed through the outer tube, and the inner tube is provided with the The second fluid channel; the outer wall of the inner tube and the inner wall of the outer tube jointly enclose the first fluid channel; the expandable member is sleeved on the inner tube, and the proximal end of the expandable member It is fixedly connected with the distal end of the outer tube and communicates with the first fluid channel.
  14. 如权利要求1-12任一项所述的消融系统,其特征在于,所述流通管道为多腔管道,所述流通管道还包括收容腔,所述收容腔与所述第一流体通道相互隔离设置,所述收容腔与所述第二流体通道相互隔离设置,所述第二导管穿设于所述收容腔。The ablation system according to any one of claims 1-12, characterized in that, the flow channel is a multi-lumen channel, and the flow channel further includes a storage cavity, and the storage cavity is isolated from the first fluid channel It is provided that the storage cavity and the second fluid channel are isolated from each other, and the second conduit is passed through the storage cavity.
  15. 如权利要求1-14任一项所述的消融系统,其特征在于,所述第一导管还包括头端,所述头端的近端设置于所述流通管道的远端;所述头端的外径由所述头端的近端向所述头端的远端减小;所述头端包括与所述第二流体通道连通的中空腔,所述第二导管穿设所述头端并从所述头端的远端露出。The ablation system according to any one of claims 1-14, wherein the first catheter further comprises a head end, the proximal end of the head end is arranged at the distal end of the flow channel; the outer end of the head end The diameter decreases from the proximal end of the head end to the far end of the head end; the head end includes a hollow cavity communicated with the second fluid channel, and the second conduit passes through the head end The distal end of the head is exposed.
  16. 如权利要求15所述的消融系统,其特征在于,所述头端的远端的周壁上设有与所述中空腔连通的喷射口,所述喷射口用于喷射所述第二流体。The ablation system according to claim 15, characterized in that, the peripheral wall of the distal end of the head end is provided with an injection port communicating with the hollow cavity, and the injection port is used to inject the second fluid.
  17. 如权利要求15或16所述的消融系统,其特征在于,所述中空腔的内壁上形成台阶,所述流通管道的远端收容于所述中空腔内并与所述台阶相抵持。The ablation system according to claim 15 or 16, wherein a step is formed on the inner wall of the hollow cavity, and the distal end of the flow channel is accommodated in the hollow cavity and abuts against the step.
  18. 如权利要求17所述的消融系统,其特征在于,所述头端的外壁涂覆有保护层。The ablation system according to claim 17, wherein the outer wall of the head end is coated with a protective layer.
  19. 如权利要求18所述的消融系统,其特征在于,所述第一导管还包括连接器,所述连接器上设有第一流体注入口与第二流体注入口,所述连接器固定套设于所述流通管道上,所述第二导管穿设于所述连接器,所述第一流体注入口用于向所述第一流体通道注入所述第一流体;所述第二流体注入口用于向所述第二流体通道注入所述第二流体。The ablation system according to claim 18, wherein the first catheter further comprises a connector, the connector is provided with a first fluid injection port and a second fluid injection port, and the connector is fixedly sleeved On the flow pipe, the second conduit is passed through the connector, and the first fluid injection port is used to inject the first fluid into the first fluid channel; the second fluid injection port Used for injecting the second fluid into the second fluid channel.
  20. 如权利要求19所述的消融系统,其特征在于,所述连接器包括第一连接器及第二连接器,所述第一连接器固定套设于所述流通管道上,所述流通管道的近端与所述第二连接器的远端固定连接;所述第二导管穿设于所述第二连接器;所述第一流体注入口设于所述第一连接器,所述第二流体注入口设于所述第二连接器。The ablation system according to claim 19, wherein the connector comprises a first connector and a second connector, the first connector is fixedly sleeved on the flow channel, and the flow channel The proximal end is fixedly connected to the distal end of the second connector; the second conduit is passed through the second connector; the first fluid injection port is arranged at the first connector, and the second The fluid injection port is arranged on the second connector.
  21. 如权利要求20所述的消融系统,其特征在于,所述第一连接器包括固定连接的第一管体与第一注入管,所述第一注入管具有所述第一流体注入口,所述流通管道穿设于所述第一管体并露出所述第一管体的近端,所述第一注入管与所述第一流体通道连通。The ablation system according to claim 20, wherein the first connector comprises a first tube body and a first injection tube fixedly connected, the first injection tube has the first fluid injection port, and The circulation channel is passed through the first tube body and exposes the proximal end of the first tube body, and the first injection tube communicates with the first fluid channel.
  22. 如权利要求20所述的消融系统,其特征在于,所述第二连接器包括固定连接的第二管体与第二注入管,所述第二注入管具有所述第二流体注入口;所述第二管体的远端与所述流通管道的近端固定连接,所述第二管体与所述第二流体通道连通,所述第二导管穿设于所述第二管体。The ablation system according to claim 20, wherein the second connector comprises a second tube body and a second injection tube fixedly connected, and the second injection tube has the second fluid injection port; The distal end of the second tube body is fixedly connected to the proximal end of the flow channel, the second tube body communicates with the second fluid channel, and the second conduit is passed through the second tube body.
  23. 如权利要求18所述的消融系统,其特征在于,所述连接器包括沿所述连接器的轴向设置的第二安装孔,所述连接器的近端面设有与所述第二安装孔连通的扩口,所述第一导管还包括密封垫,所述密封垫收容于所述扩口内并与所述连接器密封连接,所述密封垫设有第二插入孔,所述第二导管穿设于所述第二安装孔及所述第二插入孔。The ablation system according to claim 18, characterized in that, the connector includes a second installation hole arranged along the axial direction of the connector, and the proximal end surface of the connector is provided with the second installation hole. The first conduit further includes a gasket, the gasket is accommodated in the flare and is sealed with the connector, the gasket is provided with a second insertion hole, and the second The conduit passes through the second installation hole and the second insertion hole.
  24. 如权利要求19所述的消融系统,其特征在于,所述第一导管还包括与所述连接器的近端固定连接的尾盖,所述尾盖的近端设有导管孔,所述第二导管穿设于所述导管孔。The ablation system according to claim 19, wherein the first catheter further comprises a tail cap fixedly connected to the proximal end of the connector, the proximal end of the tail cap is provided with a catheter hole, and the first catheter Two conduits pass through the conduit hole.
  25. 如权利要求24所述的消融系统,其特征在于,所述尾盖包括套设部及收容于所述套设部内的接合部,所述接合部的近端与所述套设部的近端固定连接,所述导管孔贯通所述接合部的近端面与所述接合部的远端面,所述连接器的近端夹设于所述套设部与所述接合部之间。The ablation system according to claim 24, characterized in that, the tail cap comprises a sleeve part and a joint part accommodated in the sleeve part, the proximal end of the joint part and the proximal end of the sleeve part Fixedly connected, the conduit hole passes through the proximal end surface of the joint part and the distal end surface of the joint part, and the proximal end of the connector is sandwiched between the sleeve part and the joint part.
  26. 如权利要求19所述的消融系统,其特征在于,所述消融系统还包括护套,所述护套套设于所述连接器的远端,所述流通管道穿设于所述护套中。The ablation system according to claim 19, characterized in that, the ablation system further comprises a sheath, the sheath is sheathed on the distal end of the connector, and the flow channel is passed through the sheath .
  27. 如权利要求15所述的消融系统,其特征在于,所述第二导管包括金属轴管、柔性管、电极、支撑丝及电连接器,所述柔性管的远端露出所述流通管道的远端,所述金属轴管的远端与所述柔性管的近端固定连接,所述金属轴管的近端与所述电连接器固定连接,所述电极设 于所述柔性管的远端并与所述电连接器电连接以用于进行电位标测,所述支撑丝穿设于所述柔性管。The ablation system according to claim 15, wherein the second catheter comprises a metal shaft tube, a flexible tube, an electrode, a support wire and an electrical connector, and the distal end of the flexible tube exposes the distal end of the flow channel. end, the distal end of the metal shaft tube is fixedly connected to the proximal end of the flexible tube, the proximal end of the metal shaft tube is fixedly connected to the electrical connector, and the electrodes are arranged at the distal end of the flexible tube It is also electrically connected with the electrical connector for potential mapping, and the support wire is passed through the flexible tube.
  28. 如权利要求27所述的消融系统,其特征在于,所述电极还用于产生脉冲电场以对所述目标组织区域进行脉冲消融;及/或,所述电极还用于传递射频能量以对所述目标组织区域进行射频消融;及/或,所述电极还用于传递微波能量以对所述目标组织区域进行微波消融。The ablation system according to claim 27, wherein the electrodes are also used to generate a pulsed electric field to perform pulse ablation on the target tissue region; and/or, the electrodes are also used to deliver radio frequency energy to ablate the target tissue area; performing radiofrequency ablation on the target tissue region; and/or, the electrodes are also used to transmit microwave energy to perform microwave ablation on the target tissue region.
  29. 如权利要求27所述的消融系统,其特征在于,所述柔性管包括承载部及连接部,所述连接部的远端与所述承载部的近端固定连接,所述连接部穿设于所述流通管道,所述承载部位于所述流通管道外,所述电极设于所述承载部上,所述承载部包括螺旋结构及/或弯形结构,所述螺旋结构沿所述连接部的轴向螺旋延伸,所述弯形结构设置于所述承载部的最远端并相对所述连接部的轴向弯曲设置。The ablation system according to claim 27, wherein the flexible tube includes a bearing part and a connecting part, the distal end of the connecting part is fixedly connected to the proximal end of the bearing part, and the connecting part is passed through In the circulation pipe, the bearing part is located outside the circulation pipe, the electrodes are arranged on the bearing part, the bearing part includes a helical structure and/or a curved structure, and the helical structure is along the connecting part The axial spiral extends, and the curved structure is arranged at the most distal end of the bearing part and is bent relative to the axial direction of the connecting part.
  30. 如权利要求27所述的消融系统,其特征在于,所述支撑丝包括位于所述支撑丝远端的小径部和位于所述支撑丝近端的大径部,所述大径部的外径大于所述小径部的外径,所述小径部穿设于所述柔性管。The ablation system according to claim 27, wherein the support wire comprises a small-diameter portion located at the distal end of the support wire and a large-diameter portion located at the proximal end of the support wire, and the outer diameter of the large-diameter portion is The outer diameter of the small-diameter portion is larger than that of the small-diameter portion, and the small-diameter portion is passed through the flexible tube.
  31. 如权利要求27所述的消融系统,其特征在于,所述电极包括环电极及头电极,所述环电极套设于所述柔性管上并与所述电连接器电连接,所述头电极固定于所述柔性管的最远端,所述头电极与所述电连接器电连接。The ablation system according to claim 27, wherein the electrodes include a ring electrode and a head electrode, the ring electrode is sleeved on the flexible tube and electrically connected to the electrical connector, and the head electrode Fixed to the most distal end of the flexible tube, the head electrode is electrically connected to the electrical connector.
PCT/CN2022/133571 2021-11-24 2022-11-22 Ablation system WO2023093733A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111406405.1A CN116158833A (en) 2021-11-24 2021-11-24 Ablation system
CN202111406405.1 2021-11-24

Publications (1)

Publication Number Publication Date
WO2023093733A1 true WO2023093733A1 (en) 2023-06-01

Family

ID=86420547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/133571 WO2023093733A1 (en) 2021-11-24 2022-11-22 Ablation system

Country Status (2)

Country Link
CN (1) CN116158833A (en)
WO (1) WO2023093733A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117159128A (en) * 2023-11-03 2023-12-05 浙江伽奈维医疗科技有限公司 Ablation device and ablation electrode for steep pulse ablation and/or radio frequency ablation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12076071B2 (en) 2020-08-14 2024-09-03 Kardium Inc. Systems and methods for treating tissue with pulsed field ablation

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040181137A1 (en) * 2003-03-12 2004-09-16 Rodriguez Cynthia D. Catheter with contractable mapping assembly
CN1901844A (en) * 2004-01-06 2007-01-24 东丽株式会社 Balloon catheter
CN105073047A (en) * 2013-08-23 2015-11-18 高丽大学校产学协力团 Mapping ablation catheter
CN109223169A (en) * 2018-11-13 2019-01-18 上海安钛克医疗科技有限公司 Pulmonary vein is electrically isolated balloon structure
WO2021201078A1 (en) * 2020-03-31 2021-10-07 東レ株式会社 Balloon catheter and balloon catheter system
CN217391294U (en) * 2021-11-24 2022-09-09 杭州德诺电生理医疗科技有限公司 Ablation system

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040181137A1 (en) * 2003-03-12 2004-09-16 Rodriguez Cynthia D. Catheter with contractable mapping assembly
CN1901844A (en) * 2004-01-06 2007-01-24 东丽株式会社 Balloon catheter
CN105073047A (en) * 2013-08-23 2015-11-18 高丽大学校产学协力团 Mapping ablation catheter
CN109223169A (en) * 2018-11-13 2019-01-18 上海安钛克医疗科技有限公司 Pulmonary vein is electrically isolated balloon structure
WO2021201078A1 (en) * 2020-03-31 2021-10-07 東レ株式会社 Balloon catheter and balloon catheter system
CN217391294U (en) * 2021-11-24 2022-09-09 杭州德诺电生理医疗科技有限公司 Ablation system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117159128A (en) * 2023-11-03 2023-12-05 浙江伽奈维医疗科技有限公司 Ablation device and ablation electrode for steep pulse ablation and/or radio frequency ablation
CN117159128B (en) * 2023-11-03 2024-01-30 浙江伽奈维医疗科技有限公司 Ablation device and ablation electrode for steep pulse ablation and/or radio frequency ablation

Also Published As

Publication number Publication date
CN116158833A (en) 2023-05-26

Similar Documents

Publication Publication Date Title
WO2023093733A1 (en) Ablation system
WO2020026217A1 (en) Medical device
JP7335366B2 (en) Force Sensing Catheter Including Sealed Electrode Tip Assembly and Method of Assembling Same
JP6797173B2 (en) Medical device for fluid communication
US8348937B2 (en) Irrigated ablation catheter
JP5259084B2 (en) Ablation catheter with improved tip cooling
WO2018106569A1 (en) Pulmonary vein isolation balloon catheter
CN111202581B (en) Radio frequency ablation catheter for hypertrophic cardiomyopathy operation
KR20110040898A (en) Miniature circular mapping catheter
WO2019181634A1 (en) Medical device
US20210212759A1 (en) Medical device
JPWO2019181612A1 (en) Medical device
WO2019181611A1 (en) Medical device
US20240341841A1 (en) Multi-modal catheter for improved electrical mapping and ablation
CN217391294U (en) Ablation system
EP3811882B1 (en) Medical device for puncturing
CN115414111A (en) Ablation catheter and ablation system
EP3949884A1 (en) Medical device
CN112237452A (en) Ablation isolation protection device for minimally invasive intervention
CN117481790B (en) Double-ring high-density mapping ablation catheter
US20240225691A1 (en) Catheter assembly lock
JP2020025731A (en) Medical device
CN112074317B (en) Catheter and medical device for introducing therapeutic solution
CN219021501U (en) Ablation catheter and ablation system
CN219048803U (en) Multi-balloon ablation system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22897816

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE